Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Jul 4;23(9):1590–1602. doi: 10.1016/j.jamda.2022.06.028

Managing the Impact of COVID-19 in Nursing Homes and Long-Term Care Facilities: An Update

Adam H Dyer a,b,, Aoife Fallon a,b, Claire Noonan a, Helena Dolphin a, Cliona O’Farrelly c,d, Nollaig M Bourke b,e, Desmond O’Neill a,b, Sean P Kennelly a,b
PMCID: PMC9250924  PMID: 35922016

Abstract

Older adults in nursing homes are at greatest risk of morbidity and mortality from SARS-CoV-2 infection. Nursing home residents constituted one-third to more than half of all deaths during the early waves of the COVID-19 pandemic. Following this, widespread adaptation of infection prevention and control measures and the supply and use of personal protective equipment resulted in a significant decrease in nursing home infections and deaths. For nursing homes, the most important determinant of experiencing a SARS-CoV-2 outbreak in the first instance appears to be community-transmission levels (particularly with variants of concern), although nursing home size and quality, for-profit status, and sociodemographic characteristics are also important. Use of visitation bans, imposed to reduce the impact of COVID-19 on residents, must be delicately balanced against their impact on resident, friend or family, and staff well-being. The successful rollout of primary vaccination has resulted in a sharp decrease in morbidity and mortality from SARS-CoV-2 in nursing homes. However, emerging evidence suggests that vaccine efficacy may wane over time, and the use of a third or additional vaccine “booster” doses in nursing home residents restores protection afforded by primary vaccination. Ongoing monitoring of vaccine efficacy in terms of infection, morbidity, and mortality is crucial in this vulnerable group in informing ongoing SARS-CoV-2 vaccine boosting strategies. Here, we detail the impact of SARS-CoV-2 on nursing home residents and discuss important considerations in the management of nursing home SARS-CoV-2 outbreaks. We additionally examine the use of testing strategies, nonpharmacologic outbreak control measures and vaccination strategies in this cohort. Finally, the impact of SARS-CoV-2 on the sector is reflected on as we emphasize the need for adoption of universal standards of medical care and integration with wider public health infrastructure in nursing homes in order to provide a safe and effective long-term care sector.

Keywords: COVID-19, SARS-CoV-2, vaccine, nursing home, long-term care


Older adults resident in nursing homes or long-term care facilities represent those at greatest risk from infection with SARS-CoV-2, the cause of COVID-19 illness and the current pandemic.1 , 2 In comparison to their community-dwelling counterparts, older adults in nursing homes have greater levels of medical complexity, multimorbidity, frailty, and disability. Additionally, most older adults in nursing homes need assistance with personal care, and a significant number have cognitive impairment or dementia.3 , 4 In addition, there are concerns of a lack of uniform medical care standards and insufficient integration of nursing homes in the wider infrastructure of public and secondary health care in many countries.5 Collectively, this places older nursing home residents at greater risk of morbidity and mortality from viral infections, starkly highlighted in the first wave of the current pandemic where older nursing homes represented one-third to more than half of all deaths.6

Following the first wave, mortality significantly declined in nursing home residents as a result of widespread infection prevention and control measures, appropriate supply and use of personal protective equipment, and measures to increase temporarily medical supports in nursing homes.6 , 7 Measures such as visitation bans and national lockdowns, which had a significant impact in the frequency of SARS-CoV-2 infections and outbreaks in nursing homes, represented significant challenges to the mental and emotional well-being of residents, their families, and nursing home staff.8, 9, 10 Although the tremendous success of vaccination programs resulted in a sharp decline in infection and mortality rates in nursing home residents, management of breakthrough infections and associated outbreaks, particularly with variants of concern, is an ongoing challenge for the sector. This is particularly true in the face of waning vaccine efficacy over time and in periods of high community transmission, prompting the rapid and successful deployment of booster vaccinations in this cohort.11 , 12 It is clear that surveillance of ongoing vaccine effectiveness and consistent reevaluation of the potential need for future vaccine boosters is of critical importance for the sector.

In the current narrative review, we discuss the impact of the SARS-CoV-2 pandemic on nursing homes, strategies to mitigate outbreaks, the success of mass vaccination as well as highlighting current and future challenges for the sector. We reflect on the particular challenges that are unique to nursing homes in managing suspected and confirmed SARS-CoV-2 infections and discuss the need for global development of and investment in a safe and effective long-term care sector.

Clinical Presentation, Prevalence, and Risk Factors

Clinical Presentation

Older nursing home residents with SARS-CoV-2 infection may present with symptoms that differ from their younger, community-dwelling counterparts. In additional to “typical” symptoms, including dyspnea, cough, pyrexia, headache, myalgia, anorexia, and fatigue, nursing home residents may also present with delirium, diarrhea, falls, behavioral change, seizures, reduced mobility, and other so-called atypical symptoms, although the use of such terminology risks overlooking these symptoms in daily practice.13, 14, 15 Importantly, point-prevalence studies have demonstrated that a significant number (typically one-third to one-half) of older SARS-CoV-2–infected nursing home residents are asymptomatic or presymptomatic at the time of testing, which has represented a particular challenge in the early identification and management of suspected SARS-CoV-2 outbreaks.16, 17, 18, 19, 20, 21

SARS-CoV-2 Prevalence in Nursing Homes

Nursing homes were most affected by SARS-CoV-2 outbreaks during the first wave of the pandemic; however, estimates vary widely. During March-May 2020, an estimated one-third to two-fifths of Scottish and English nursing homes experienced an outbreak, mirrored internationally, although data may be limited because of lack of accurate diagnostic data during the first wave.22, 23, 24, 25 Following this, with changing epidemiology and adoption of infection prevention and control measures, personal protective equipment usage, and the subsequent deployment of vaccination campaigns, SARS-CoV-2 prevalence in nursing homes decreased throughout 2020, including by 80.6% in one large English study.26 Similarly, a German study examining data over 4 SARS-CoV-2 waves since March 2020 noted a significant decline in long-term care facility outbreaks during the third and fourth waves in comparison to first and second waves.27 In an updated analysis, pooled data from 14 countries indicated a prevalence of 2.2% of occupied beds in Finland to 50% in the United States has been reported until October 2021, with most countries reporting previous infections in between 1/10th of 1/3rd of all residents infected.6 More recent estimates of infection (and reinfection) prevalence, in the face of wide Omicron transmission, are unclear.

Most studies rely on diagnostic figures from outbreak characterization, screening and results of reverse transcription polymerase chain reaction (RT-PCR) testing for case identification. However, unique large-scale seroprevalence studies offer an insight into the true prevalence of past SARS-CoV-2 infection in residents. For instance, in the VIVALDI study, residents from 100 population-representative long-term care facilities in England underwent assessment for serial serum IgG antibodies throughout 2020.28 Of these, a striking one-third had a reactive anti–nucleocapsid IgG result indicating previous infection.29 However, antibody levels decay over time, and there may be a limited window in which these studies can be conducted to further clarify how many residents were infected with SARS-CoV-2 during the course of first waves of the pandemic.28 , 30 Thus, further seroepidemiologic studies are warranted.

Breakthrough Infections Postvaccination and Emergence of Variants of Concern

Despite declines in SARS-CoV-2 infection prevalence and successful vaccine rollout, breakthrough infections and outbreaks continued to occur throughout 2021, both in nursing home residents and staff previously vaccinated, increasing in number and scale prior to rollout of booster vaccine doses.31, 32, 33, 34, 35, 36, 37 One report assessing data from 10 European Countries on 240 outbreaks from July to October 2021 noted this increasing risk, with 22.2% of residents affected, 10.2% of whom died.38

Importantly, evidence suggests that such “breakthrough” outbreaks postvaccination were associated with fewer case numbers per outbreak and both lower morbidity and mortality than the first 2 pandemic waves.27 , 38, 39, 40 Increasingly, SARS-CoV-2 outbreaks in nursing home populations reflect circulating variants of concern, tied closely to strains circulating in the wider community. This includes documented outbreaks in nursing homes of the delta,41 , 42 gamma,43 , 44 alpha,45 , 46 and beta47 , 48 strains. Although early epidemiologic data for the Omicron variant suggest increased risk of infection and milder disease course compared to other variants of concern in vaccinated or previously infected individuals, the full impact of the Omicron variant on nursing homes is not currently clear.49 , 50

Risk Factors for SARS-CoV-2 Infection in Nursing Homes

A body of research has emerged focusing on risk factors for SARS-CoV-2 outbreaks within nursing homes (Table 1 ). Most importantly, the likelihood of a SARS-CoV-2 outbreak appears most closely tied with the community-level prevalence of SARS-CoV-2 infection and nursing home size.22 , 25 , 51, 52, 53, 54, 55 The relationship between staffing levels and likelihood of SARS-CoV-2 outbreaks is less certain, with both lower and higher staff numbers associated with likelihood of SARS-CoV-2 outbreaks in early reports.16 , 23 , 57 , 58 , 66 However, there are issues apart from absolute staffing numbers that may influence this relationship. In a nationwide study in England, the likelihood of SARS-CoV-2 outbreak was significantly lower per unit increase in the staff-to-bed ratio and significantly lower in facilities that paid staff statutory sick pay.60 Notably, staff caring for both infected and uninfected residents significantly increased risk of infection in residents as did frequent use of agency staff.60 Thus, the link between staffing levels and outbreak likelihood may not reflect staff number, but other issues related to SARS-CoV-2 transmission between nursing home staff and residents, particularly in periods of high community transmission, which is closely coupled to outbreak likelihood.

Table 1.

Risk Factors Associated With Experiencing a COVID-19 Outbreak in Nursing Homes and Long-Term Care Facilities

Risk Factor References Summary
Community transmission 22,25,51
  • Scotland, N = 334 care homes: Increased likelihood of outbreak with rising community prevalence (OR = 1.2 per 100 cases/100,000 population increase)22

  • France, N = 943 nursing homes: Strong correlation (R 2 = 0.71) between population peaks and outbreak peaks in nursing homes25

  • Ontario, Canada, N = 770 facilities: Increased likelihood of outbreak with increasing regional prevalence51

Nursing home characteristics
 Nursing home size 22,25,51, 52, 53, 54, 55
  • Scotland, N = 334 care homes: Increasing facility size (>90 vs <20 beds) linked with increased likelihood of outbreak (adjusted OR: 55)22

  • USA, N = 9395 facilities: Increased likelihood in medium (50-150 beds; adjusted OR: 2.63) and large (>150 beds; adjusted OR 6.52) vs small (<50 beds) facilities via public/state reports53

  • Systematic review, N = 36 studies in USA: Community prevalence and increasing nursing home size linked to greater likelihood of outbreak52

 Nursing home design 56
  • USA, N = 219 facilities: Non-traditional “Green House” Design associated with fewer outbreak cases56

Nursing home staffing
 Absolute staff numbers 57, 58, 59
  • USA: Lowest quartile of unique employees associated with lower deaths than highest quartile (6.2 cases per 100 beds vs 11.9 per 100 beds) in US skilled nursing facilities58

  • France, N = 57 nursing homes: Significant correlation between staff and resident cases57

  • USA, N = 13,157 facilities: Increasing likelihood of outbreak with greater number of registered nurse hours59

 Staff-resident ratio 23,60
  • UK, N = 179 facilities: Lower staff-beds ratio an independent risk factor for likelihood of infection23

  • England, N = 5126 facilities: Reduced risk (adjusted OR: 0.63) of infection per unit increase in staff-bed ratio60

 Staff statutory sick pay available 60
  • England, N = 5126 facilities: Statutory sick pay available associated with reduced risk of resident infection (adjusted OR: 0.70)60

 Staff cohorting 60
  • England, N = 5126 facilities: Not cohorting staff in contact with infected residents associated with greater likelihood of infection (adjusted OR: 1.20)60

 Frequent employment of agency nurses and carers 60
  • England, N = 5126: Agency staff most days or every day associated with greater likelihood of infection (adjusted OR: 1.85)60

Nursing home quality and for-profit status
 Nursing home quality ratings 58,59,61, 62, 63, 64, 65
  • USA, N = 123 facilities: Lower likelihood of outbreak with increasing CMS Five-Star Rating62

  • USA, N = 713 facilities: Higher CMS rating associated with lower likelihood of outbreak among staff and residents63

  • USA, N = 1223 facilities: CMS rating significantly linked to having both resident infection and death64

  • USA, N = 15,390: COVID-19 cases and deaths significantly higher in nursing homes with a lower rating65

 For-profit status 60,63
  • England, N = 5126 facilities: For-profit status associated with increased risk of outbreak (adjusted OR: 1.19)60

  • USA, N = 713 nursing homes: Greater outbreak size (12.7 times larger) in for-profit vs nonprofit counterparts63

OR, odds ratio.

A number of studies, mainly in the United States, have examined the relationship between nursing home quality and SARS-CoV-2 outbreaks, with conflicting findings.58 , 59 , 61 Findings from a study in West Virginia examining the relationship between SARS-CoV-2 outbreaks and Centers for Medicaid & Medicare Services (CMS) Five-Star Quality Ratings reported a lower likelihood of outbreak with increasing rating, which was replicated in 2 Californian studies and in a large study of more than 15,000 Medicare- and Medicaid-certified nursing homes.62, 63, 64, 65 This was only partially explained by for-profit status.67 A larger study of 8943 nursing homes in 23 states did not replicate this finding, although outbreak-affected nursing homes had more mean health deficiencies, emergency preparedness deficiencies, and substantiated complaints.68 Overall, there does seem to be some evidence linking nursing home quality, staffing, and for-profit status with likelihood of outbreak, although this is yet to be fully elucidated.

Architectural design has been a relatively neglected consideration in pandemic preparedness of nursing homes, with evidence suggesting that smaller Green House type nursing homes are associated with lower case numbers and mortality.56 Within this context, other issues such as site location, ventilation, and access to outdoor space are likely to be important.69

Risk Factors for Mortality From SARS-CoV-2 in Nursing Home Residents

Mortality from COVID-19 in Nursing Home Residents

Older nursing home residents comprised roughly one-third to half of deaths in the first wave of the SARS-CoV-2 pandemic.70, 71, 72 Exact estimates vary by study design, methodology, and statistical approach; however, an excess number of total deaths in the first half of 2020 in nursing homes was reported. For instance, roughly 20,000 excess deaths in care homes in England and Wales and 15,000 excess deaths in France were reported during the first wave,73, 74, 75 reflecting an excess in all-cause mortality for nursing home residents in 2020 compared with previous years.76 A recent analysis of data from 14 countries until October 2021 that nursing home residents represented 11% of all COVID-19 deaths in Czech Republic and up to 50% in Belgium.6 For residents infected with SARS-CoV-2, estimates of case-fatality vary from 20% to 50% for older nursing home residents, with a pooled estimate of 23% in one meta-analysis.77

An important concern in estimating nursing home COVID-19 deaths centers around the potential underreporting of deaths in some jurisdictions,78 , 79 although this must be carefully balanced against the potential for retrospective attribution bias.80 Mirroring the prevalence data reviewed above, mortality figures in nursing home residents decreased after the first wave, as seen in a study of more than 4 million older adults conducted in England.7 The initial decline in mortality from March to November 2020 was seen with widespread infection prevention and control measures, personal protective equipment usage and experience managing COVID-19 illness81 was followed by further reductions after mass vaccination, reviewed below.

Risk Factors for Mortality in Nursing Homes

At an individual level, increasing age and frailty increase the risk of SARS-CoV-2 mortality among those infected.82, 83, 84, 85, 86, 87 Additionally, male sex,82, 83, 84 , 86 , 88 , 89 dementia and neuropsychological conditions,82 , 86 , 90 urinary and bowel incontinence,82 diabetes,82 chronic kidney disease,82 , 84 , 91 cardiovascular disease,84 previous pneumonia or respiratory disease,82 greater levels of dependency,83 , 85 , 86 , 88 malnutrition, and dehydration risk in addition to overall medical comorbidity92 have all been associated with greater mortality from SARS-CoV-2 infection in nursing home residents. In terms of acute COVID-19 illness, symptomatic disease (particularly pyrexia and dyspnea), need for supplemental oxygen and oxygen desaturation, bilateral radiographic infiltrates and abnormalities on routine laboratory tests such as higher C-reactive protein (CRP) or interleukin-6 (IL-6), lymphopenia, lower GFR, hemoglobin concentration, hypernatremia, and reduced serum albumin have been associated with a greater risk of mortality in nursing home residents with SARS-CoV-2 infection (Table 2 ).92, 93, 94, 95

Table 2.

Risk Factors for Mortality in Nursing Home Residents

Risk Factor References Summary
Individual characteristics
 Age 82,84,87
  • Sweden, N = 3731 residents: 30-day mortality greater aged >80 y (adjusted OR 2.99) and >90 y (adjusted OR 3.28) vs those aged <70 y82

  • Spain, N = 2140 residents; N = 9121 from general population: Greater risk of mortality in nursing home residents aged >80 y84

  • France, N = 480 infected residents: greater mortality risk in residents aged >85 y (OR 2.36)87

 Male sex 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93
  • Sweden, N = 3731 residents: Male sex associated with greater 30-day mortality (OR 2.60)82

  • USA, N = 5256 residents: women had a lower 30-day mortality than men (HR 0.69)93

 Dementia and neuropsychological conditions 88,90,93
  • Spain, N = 842 residents: Moderate/severe dementia associated with greater mortality (adjusted OR: 2.64)88

  • Netherlands, N = 1294 residents: Dementia associated with an increased 30-d mortality (HR: 1.3)90

  • USA, N = 5256 residents: Severe cognitive impairment associated with greater risk of 30-d mortality (OR: 2.79)93

 Diabetes 82,93
  • USA, N = 5256 residents: Diabetes associated with greater risk of 30-day mortality (OR: 1.21)93

  • Sweden, N = 3731 residents: Diabetes associated with greater likelihood of COVID-19 mortality82

 Chronic kidney disease 84,91,92
  • USA, N = 6798 residents: Poorer kidney function associated with greater likelihood of mortality91

  • Sweden, N = 3731 residents: Chronic kidney disease associated with greater mortality82

  • Canada, N = 5029 residents: Lower eGFR associated with greater mortality92

 Cardiovascular disease 84,92
  • Spain, N = 3567 residents: Cardiovascular Disease associated with mortality in 3567 nursing home residents (OR: 1.49)84

  • Canada, N = 5029: Cardiovascular comorbidities and heart failure associated with increased mortality92

 Greater dependency and poorer physical function 88,92,93
  • Spain, N = 842 residents: Greater Barthel Index associated with greater likelihood of mortality (adjusted OR: 5.03)88

  • Canada, N = 5029 residents: Poorer function on activities of daily living and pressure ulcer risk scores linked with greater mortality92

  • USA, N = 5256 residents: Functional dependence associated with greater mortality in 1185 residents admitted to hospital93

COVID-19 illness characteristics
 Symptomatic disease (pyrexia and dyspnea) 89,92, 93, 94, 95
  • Italy, N = 382 residents: Symptomatic illness associated with greater mortality (HR: 3.99)89

  • Spain, N = 1185 residents: Fever (OR:1.67) and dyspnea (OR: 1.66) associated with mortality in those admitted to hospital94

 Bilateral pulmonary infiltrates 93,94
  • Spain, N = 1185 residents: bilateral infiltrates on chest radiograph associated with greater mortality (OR: 1.98)93

 Hypoxia 94
  • Spain, N = 1185 residents: Hypoxia associated with 30-d inpatient mortality (OR: 2.05)94

 Routine laboratory abnormalities
Higher C-reactive protein and interleukin-6 (IL-6)
Lymphopenia, hypernatremia, lower albumin
92, 93, 94, 95
  • Canada, N = 5029 residents: Lower hemoglobin, lymphocyte count, and serum albumin associated with higher mortality92

  • Spain, N = 1185 residents: High C-reactive protein (CRP) associated with mortality94

  • Italy, N = 50 residents: High IL-6 associated with mortality95

Facility-level characteristics
 Racial and ethnic composition of nursing homes 96, 97, 98
  • USA, N = 13,123 facilities: Racial and ethnic composition linked to increased death rates in high-minority communities96

  • USA, N = 51,606 COVID-19 deaths: Mean number of deaths in nursing homes with the lowest proportion of White residents significantly greater than those with the greatest proportion of White residents97

 Area-level socioeconomic deprivation 99
  • England, N = 149 facilities: COVID-19 deaths more common in the most deprived quartiles of Income Deprivation Affected Older People Index (IDAOPI) (IRR: 1.23)99

 Larger nursing homes and larger providers 75,100
  • USA, N = 1162 facilities: Greater number of total beds and a greater occupancy rate associated with greater likelihood of experiencing 6 or more COVID-19 deaths100

  • England, N = 29,542 deaths: Greater COVID-1– attributable death with large provider (OR 1.2) and larger vs smaller facilities (OR 13.3)75

 For-profit status 100
  • USA, N = 1162 facilities: For-profit status independently associated with greater likelihood of experiencing more than 6 COVID-19 deaths100

 Nursing home quality 64,65
  • USA, N = 1223 facilities: Significantly lower likelihood of death with a 5-star CMS rating64

  • USA, N = 15,390 facilities: 30% higher deaths in nursing homes with 1-star CMS ratings65

eGFR, estimated glomerular filtration rate; HR, hazard ratio; IRR, incidence rate ratio; OR, odds ratio.

At a facility level, several studies have reported significant associations between the racial and ethnic composition of nursing homes mortality from SARS-CoV-2 infection,96 with higher mortality rates of non-White residents.97 These system-level disparities have been replicated across multiple studies.98 Similarly, area-level socioeconomic deprivation was associated with SARS-CoV-2 mortality in nursing home residents.99

A large study in England demonstrated greater mortality in larger homes and those belonging to a large provider, but no relationship between for-profit status and mortality.75 A study in Connecticut, New Jersey, and New York reported more total beds, higher occupancy rates, and being a for-profit facility associated with greater mortality.100 Although associations between nursing home quality and mortality are less clear, a 1-star CMS rating was associated with a 30% higher likelihood of death from SARS-CoV-2 in an American study of more than 15,000 nursing homes.65 The link between quality and mortality has subsequently been replicated across several studies.64 , 98 In sum, it appears that racial and ethnic composition, socioeconomic deprivation, and nursing home quality may be important factors in COVID-19 mortality risk. Risk factors for COVID-19 mortality in nursing home residents are summarized in Table 2.

SARS-CoV-2 Testing and Screening in Nursing Homes

When discussing SARS-CoV-2 testing approaches, it is important to remember that incidence in nursing homes is closely coupled to community transmission and in many cases is asymptomatic or presymptomatic.101 , 102 Overall, screening and testing strategies differ across jurisdictions in the early pandemic, but consensus largely supports regular point prevalence testing in periods of high community transmission before mass vaccination. Where an outbreak is identified, the evidence largely supports serial and universal swabbing of residents and staff, with most research conducted prevaccination.

RT-PCR, performed using nasopharyngeal/throat/saliva swab, is consistently the most reliable test in the diagnosis of SARS-CoV-2 infection.103 , 104 The sensitivity of RT-PCR is about 90% in nursing home residents and can readily uncover asymptomatic and presymptomatic infection, although false negatives may occur.105 Of note, PCR results may remain positive in nursing home residents for longer than 14 days, and indeed the rate of repeat positive tests in nursing home residents is significantly greater than those seen in younger adults.106 , 107 The use of universal and serial RT-PCR during outbreaks has demonstrated efficacy in permitting the identification and isolation of residents with symptomatic and asymptomatic SARS-CoV-2 infection,108 particularly in the early waves of the pandemic, when levels of community transmission are high before mass vaccination.

Many reports advocate for mass testing following the identification of a single suspected or confirmed case of SARS-CoV-2 infection, followed by repeated testing on days 4-7 in those with a negative result.109 At the start of the pandemic, the absence of widespread testing was consistently highlighted as an important problem in many countries.109 There is now strong evidence that mass testing following an identified SARS-CoV-2 case may rapidly identify additional cases in staff and residents not identified through targeted symptom-based testing.110, 111, 112, 113 In outbreak-free nursing homes during periods of low community transmission, the evidence is less clear. Although some benefit is seen with mass screening of residents,114 some modeling studies suggest that the added benefits of mass universal screening in outbreak-free nursing homes are mostly negated when coupled with high-quality infection control practices, supporting the combination of outbreak testing with high-quality infection prevention and control measures.115

Concerns with cost and availability of RT-PCR testing in nursing home residents led many investigators to evaluate the use of rapid antigen testing in this context. Although rapid antigen tests demonstrate lower sensitivity than RT-PCR testing, they may identify residents with shedding of replication-competent virus and thus identify infectious rather than asymptomatic or presymptomatic individuals, and have demonstrated utility particularly in early outbreaks in nursing homes.116 , 117 However, evidence supporting their use is more limited than RT-PCR. Early in the pandemic, approaches to screening also included screening of temperature and vital signs. However, use of temperature thresholds may fail to identify the majority of nursing home residents with SARS-CoV-2 infection,118 and even with reducing fever thresholds, have limited sensitivity and specificity in the identification of SARS-CoV-2 infection,119 making them unlikely to detect infection when used as a screening tool.120

In summary, testing strategies in nursing homes must take into account community-transmission, wider epidemiologic trends including mass vaccination, boosters, and emergence of variants of concern. The approach to testing in the current climate of widespread transmission of the Omicron variant in the community is less clear, but supports testing symptomatic individuals as well as close-contacts in nursing homes, in addition to mass testing once an outbreak is detected.

Key Issues in the Management of COVID-19 Outbreaks in Nursing Homes

Nonpharmacologic and Infection Control Measures

Apart from the successful rollout of vaccinations within nursing homes, the most substantial impact on the number and severity of outbreaks has come from nonpharmacologic interventions targeted at mitigating the impact of SARS-CoV-2 outbreaks on residents. In line with testing strategies outlined above, swift identification of SARS-CoV-2 infection in nursing homes, appropriate use of PPE, and appropriate infection prevention and control measures have all demonstrated efficacy in managing individual outbreaks (Table 3 ).

Table 3.

Nonpharmacologic Approaches to Mitigate COVID-19 Outbreaks and Mortality in Nursing Homes and Long-Term Care Facilities

Mitigation Measures References Summary
Nursing home infection prevention and control measures
 Mass resident screening 121, 122, 123
  • Rapid systematic review of European, American, and Asian studies, N = 38 studies: Supports use of mass testing in outbreak-affected facilities121

  • Cochrane Review, N = 11 modeling and 11 observational studies: Testing of new admissions and intensified testing of residents and staff after holidays may reduce infections123

  • Cochrane Review, N = 11 modeling and 11 observational studies: Routine testing may reduce infection rates123; however evidence noted as uncertain

 Resident cohorting and physical separation of infected residents 121, 122, 123, 124, 125, 126, 127, 128, 129
  • Rapid systematic review of European, American, and Asian studies, N = 38 studies: supports cohorting protocols to reduce infection rates; however, data limited121

  • Cochrane Review, N = 11 modeling and 11 observational studies: supports use of cohorting to reduce new infections but evidence remains uncertain123

  • USA, N = 360 facilities: decline in weekly infection rates with implementation of infection prevention and control procedures122

  • UK, agent-based modeling study: supports ongoing use of cohorting protocols in outbreak-affected nursing homes129

 Promoting hand and respiratory hygiene 121,122,130
  • USA, N = 2580 residents: Greater implementation of hand and respiratory hygiene associated with lower infection rates130

 Environmental cleaning 123,130
  • USA, N = 2580 residents: Greater implementation of environmental cleaning associated with lower infection rates130

  • Cochrane Review, N = 11 modeling and 11 observational studies: Cleaning and environmental hygiene measures may reduce infection rates but evidence uncertain123

Personal protective equipment
 Supply of personal protective equipment 122,131,132
  • USA, N = 360 facilities: Rapid decline in infection rates following widespread use of personal protective equipment in a large cohort study122

  • Cyprus, N = 5115 facilities: decline in infection rates during intervention period with adoption of personal protective equipment131;

  • USA, stochastic modeling study: Supports continued need for use of personal protective equipment in outbreak-affected facilities despite mass vaccination132

 Training of staff in use of personal protective equipment 133
  • Belgium, N = 617 health care workers: Decreased infections when staff appropriately trained in personal protective equipment use133

Wider societal measures
 Visitation bans 123,129,134,135
  • USA, meta-population modeling study: Reduction in infection rate in areas imposing visitation bans134

  • UK, agent-based modeling study: Reduced infections with visitation bans only when community prevalence where staff live considerably lower than prevalence where visitors live129

  • UK, N = 57,713 individuals: “shielded” individuals had higher rates of infection, after adjustment for nursing home status135

  • Cochrane Review, N = 11 modeling and 11 observational studies: Evidence uncertain to support visitation bans123

Interventions to support outbreak-affected nursing homes
 On site medicalization 136,137
  • Spain, N = 272 residents: On-site medicalization associated with a significantly greater compositive of survival or optimal palliative care136

  • USA, N = 215 residents: partnering with local hospitals successfully implemented, descriptive study137

 Outreach teams 138,139
  • Netherlands, N = 41 long-term care organizations: Outbreak team monitoring successfully implemented, descriptive study138

  • France, N = 63 facilities: Local multidisciplinary mobile team implemented to successfully manage outbreaks139

 Telemedicine 140, 141, 142, 143
  • USA, protocol development to identify telemedicine disruptions and solutions in supporting long-term care facilities: development and validation of several telemedicine platforms through quality improvement cycles142

  • Europe, WONCA statement: expert consensus statement on the development of optimal telemedicine support143

Despite a large number of published studies, there is a lack of high-quality evidence in the literature supporting any one or composite measure. This is mainly driven by the need for urgent response in the containment of SARS-CoV-2 outbreaks in the pandemic, particularly in the first wave and a consequent lack of formal randomized controlled trials (clearly unethical given the severity of SARS-CoV-2 outbreaks in nursing homes). Several reviews have supported attention to appropriate use of personal protective equipment (and appropriate training in same) and rigorous infection control procedures, including attention to meticulous hand hygiene and appropriate cohorting.121 , 122 , 124, 125, 126, 127, 128

A Cochrane review of nonpharmacologic measures to limit the spread of SARS-CoV-2 notes that most modeling studies and observational studies demonstrated uncertain results. Although visiting restrictions may reduce the number of infections and deaths, there was no clear evidence to support this.123 This review did, however, support the use of protective masks, appropriate personal protective equipment use, cohorting, and surveillance measures.123 It is difficult to estimate the true effect of any one nonpharmacologic intervention because of spatial and temporal variation in transmission. Overall, it appears that there were lower rates of SARS-CoV-2 infection in facilities with greater infection prevention and control measures.130 , 131 Similarly, in studies from the first wave, facilities with personal protective equipment shortages were more likely to experience SARS-CoV-2 outbreaks,144 with proper training of staff in the use of personal protective equipment crucial in reducing SARS-CoV-2 transmission.133

Importantly, modeling studies in nursing homes suggest an ongoing need for appropriate nonpharmacologic interventions even following the introduction of widespread vaccination, and lack of adherence to appropriate infection prevention and control procedures and provision or use of personal protective equipment in outbreak settings may mitigate some of the benefit of vaccination among residents.132

Impact of Wider Societal Measures and Visiting Bans on Mitigating COVID-19 Outbreaks

An open question remains around the use of wider measures to prevent outbreaks in the first instance. Visitor bans widely adopted in several countries remained controversial, and many commentators note that the potential protection afforded must be balanced against the potential impact on residents’ emotional and mental well-being. Although some evidence from modeling studies suggests that nursing home visiting bans were associated with a decrease in the basic reproductive number using a mechanistic meta-population model,134 other evidence suggests that “shielding” of residents is not as effective as other nonpharmacologic measures such as appropriate infection prevention and control measures, and may be less effective in nursing home residents than shielding vulnerable adults in the wider community at periods of high community transmission.129 , 135 Thus, there is currently unclear evidence to support blanket visitor bans and shielding on older nursing home residents.

On-Site Medicalization, Outreach Teams, and Telemedicine

In managing a nursing home SARS-CoV-2 outbreak, a significant number of studies have emphasized the use of acute support (from hospital outreach teams, on-site medicalization interventions, and mobile geriatric medicine teams) in reducing hospital transfers and supporting outbreak management.136, 137, 138 Support platforms have included access to multidisciplinary decision support, specialist phone hotlines, mobile geriatric medicine teams, and videoconferences on SARS-CoV-2 outbreak management.139 , 140 Such platforms were developed in several countries and provided crucial support to nursing homes experiencing outbreaks.

A further area that saw increasing attention during the management of SARS-CoV-2 outbreaks in nursing homes is the use of telemedicine to support the provision of health care at a distance, reducing hospital admissions and improving medical care with geriatrician, psychiatric, and palliative care input in nursing homes.141 Important aspects include staff motivation, engagement with the process, as well as dedicated time, equipment, and space for telemedicine consultations to occur.142 However, although during the pandemic telemedicine was adopted to limit interaction, it may have negative effects on the quality of the doctor-patient relationship, the quality of physical examination, and provision of care.143 The exact role of telemedicine in managing future outbreaks is yet to be fully elucidated, but has been a crucial support throughout the pandemic for outbreak-affected nursing homes.

Advance Care Planning and Palliative Care in Nursing Homes During COVID-19

The COVID-19 pandemic has a substantial impact on the provision of appropriate palliative care in nursing home settings and significantly disrupted the provision of appropriate end-of-life care.145 For instance, in addition to other end-of-life routines not being followed, relatives were only present at time of death in a minority of cases in one study.146 Additionally, in those dying from COVID-19, fewer discussions were had about end-of-life care in comparison to the year previous.146 , 147 Similarly, studies have reported that in residents dying from COVID-19 illness, fewer physical examinations by doctors occurred prior to death, pain and oral health were less likely to be assessed, and fewer had formal palliative care input.148

A study in Dutch nursing homes during the first wave of the pandemic highlighted several features as part of advance care planning (ACP), including COVID-19 illness as the trigger for ACP discussion, a higher frequency of discussions, less face-to-face contact with decision makers, in addition to the additional discussion around intensive care unit admission as informing the provision of adequate end-of-life care.149 Studies have reported several proactive measures to increase ACP in nursing homes during the pandemic, including online ACP training and information for staff and family members150 and structured discussion tools, prioritized in individuals without an advanced care plan in place.151

Clinical Efficacy of Vaccination in Nursing Homes

The greatest impact on infection rates, morbidity, and mortality from SARS-CoV-2 in nursing homes has been mass vaccination programs. Impressive evidence from studies in tens of thousands of residents, staff, and health care workers has demonstrated an 81% to 90% reduction in SARS-CoV-2 infection across all groups accompanied by a significant reduction in mortality for nursing home residents at up to 6 months following primary vaccination.152 , 153 Findings demonstrating decreased infection rates, spread of SARS-CoV-2, and mortality following primary vaccination have been widely replicated.26 , 154, 155, 156, 157, 158, 159 Although vaccine efficacy may have been reduced with the emergence of variants of concern, in particular with widespread circulation of the delta strain in several countries, vaccination in nursing home residents has demonstrated significant protection against infection, severe disease, and mortality in the context of widespread community transmission.160

However, recent evidence has emerged demonstrating a decline in vaccine efficacy over time following a primary course of vaccination. In VIVALDI, real-world vaccine efficacy measured in terms of infection and mortality in nursing home residents significantly declined after just 12 weeks.12 Importantly, a “booster” or third vaccine dose restored vaccine efficacy and maximized immunity across all outcomes.12 This is in line with strong evidence from large well-conducted studies demonstrating the restoration of vaccine efficacy following a third mRNA vaccine.161 Additionally, evidence from Israel, the first country to administer booster vaccines to residents in long-term care facilities, demonstrated a reduction of 71% for overall infection and an 80% reduction in hospitalization in nursing home residents.11 There is limited data on how long the protection afforded from a third dose of mRNA vaccine lasts in terms of SARS-CoV-2 infection and COVID-19 mortality. Findings such as those from VIVALDI support the need for ongoing surveillance of vaccine efficacy in this cohort to inform future vaccine and booster strategies in this vulnerable cohort.

Humoral and Cellular Immune Responses to Vaccination in Nursing Home Residents

A wealth of evidence has accumulated to support the immunogenicity of SARS-CoV-2 vaccination in older nursing home residents. Traditional vaccines (eg, influenza, pneumococcal, and herpes zoster) are typically less efficacious in this group, prompting early concern that this may be the case for SARS-CoV-2 vaccination. A large number of studies have now evaluated the immunogenicity of SARS-CoV-2 vaccination in residents by examining longitudinal effects of vaccination on measures of humoral and cellular immunity.

It is quite clear from these studies that the largest predictor of humoral and cellular immune responses is history of past SARS-CoV-2 infection.162 , 163 Despite some studies, this has prompted authors to suggest that only a single vaccine dose may be required in those with past SARS-CoV-2 infection164 , 165; more recent longitudinal studies have suggested that 2 doses are required to reach population homogeneity in vaccine efficacy among nursing home residents.166 Nevertheless, the clear effect of SARS-CoV-2 in shaping future immune responses to SARS-CoV-2 hints that with appropriate antigenic exposure, older nursing home residents can mount durable protective immune responses.

Studies examining humoral immune responses to vaccination have considered both postvaccination antibody titer (total IgG/IgA titers) and neutralization capacity (the ability of serum antibodies to inhibit the ACE2-spike receptor-binding domain interaction) to Wuhan strain SARS-CoV-2 and variants of concern antigens. Overall, humoral responses (both antibody titer and neutralization) in nursing home residents are significantly lower than their community-dwelling (and typically younger) counterparts.167 Although detectable antibody titers and neutralization capacity are present in residents up to 7 months after primary vaccination,168 , 169 titers and neutralization capacity significantly wane over time,170, 171, 172 in particular for beta and gamma variants of concern.173 The complex relationship between antibody waning and protection from breakthrough SARS-CoV-2 infection is yet to be fully elucidated.

In studies examining cellular immunity (typically assessed via T-cell interferon-γ production on exposure to SARS-CoV-2 spike antigen), nursing home residents retained cellular immunity induced in the immediate period postvaccination to SARS-CoV-2 spike at 6 months despite significant decline in antibody titer over time.174 , 175 However, this response was lower in residents than younger individuals176 , 177 up to 6 months post primary vaccination.178 Taken together, these early studies indicate a reduced immunogenicity of SARS-CoV-2 vaccines in older nursing home residents in comparison to their younger, community-dwelling counterparts (typically health care worker volunteers), supporting the use of a third vaccine dose in this cohort.

Recent evidence has emerged supporting the immunogenicity of a third or booster dose in nursing home residents producing antispike, anti–receptor-binding domain, and neutralization titers above prebooster levels.179 In a longitudinal Canadian study, this represented 95% of residents achieving an antispike level consistent with 80% protection from symptomatic infection, in comparison to 81% of residents achieving this level after their initial primary vaccine course.179 This hints that vaccine boosters may allow a significantly greater duration of protection than the initial 6-month interval between primary vaccination and booster doses. Certainly, these data are in agreement with the epidemiologic data from studies such as VIVALDI (discussed above) in supporting the use of vaccine boosters after primary vaccination in nursing home residents. The duration of protection afforded from booster doses, in addition to the longitudinal kinetics of antibody responses postvaccination, in this cohort is yet to be determined and an area of active research and surveillance. This will be particularly important in moving from studies of humoral and cellular immunity to correlates of protection to SARS-CoV-2 infection in nursing home residents.

Currently, the exact relationship between antibody titers and breakthrough infections is still unclear. However, an important study in just under 400 residents from 7 nursing homes demonstrated an association between greater vaccine-induced anti–receptor-binding domain IgG levels and protection from infection in nursing homes experiencing an alpha variant of concern SARS-CoV-2 outbreak, encouraging further research into protective thresholds and clinical implications of waning antibody titers in this cohort.180 Although many studies have longitudinally profiled measures of humoral and cellular immunity to SARS-CoV-2 in residents following vaccination, key “critical thresholds” are yet to be determined that afford residents protection from future SARS-CoV-2 infection. This is particularly important in population-level estimation of protection from SARS-CoV-2 outbreaks in nursing homes and in informing ongoing vaccination strategy, both in terms of the need for future vaccine boosters and the intervals at which this should occur in nursing home residents.

Vaccination of Staff in Nursing Homes

Alongside vaccination of residents, vaccination against SARS-CoV-2 among staff members working in nursing homes is extremely efficacious. A recent study using data from 12,364 nursing homes in the United States demonstrated that lower staff vaccine coverage was associated with significantly greater additional SARS-CoV-2 infections and deaths in residents.181 However, there have been significant barriers to vaccine uptake in some settings, with wide variation reported.182, 183, 184 An early analysis of vaccination data in 14,900 American nursing homes reports that for-profit ownership was associated with lower rates of vaccine coverage, whereas increasing CMS Five Star Rating, a greater proportion of longer-tenured staff, and overall county-level vaccination were associated with greater uptake.185

In some jurisdictions, mandatory vaccination has been used as a condition of employment for care home staff.186 , 187 Additionally, other measures have been deployed to encourage vaccine uptake among staff in nursing homes. Studies have demonstrated a significant impact of designated frontline staff champions, vaccination goals, nonmonetary rewards,188 and have highlighted the importance of peer uptake on influencing vaccine hesitancy.189 It is important to note the results of qualitative studies that have reported the presence of misinformation about vaccine development and side effects in some nursing home staff, highlighting the key role for both social and traditional media as an important source of reliable vaccination information.190 , 191

Psychological Impacts of the COVID-19 Pandemic and Lockdown Measures

Psychological Impact on Residents

Both the COVID-19 pandemic itself in addition to infection control measures and visiting bans had profound impact on mental health and well-being of nursing home residents.8 Throughout the first year of the pandemic, both the pandemic itself and visiting bans have been linked to increased risk of depressive symptoms in residents192 in addition to worsening of preexisting depression.193 Similarly, the prevalence of depressive symptoms significantly increased in comparison to prepandemic levels in one longitudinal study,194 and studies have suggested a decline in cognitive function and an increase in depressive symptoms following the strict lockdown measures.195

Qualitative work has demonstrated the influence of strict lockdowns and visiting bans on feelings of loneliness in nursing home residents.196 Data from the National Health and Aging Trends Study (NHATS) demonstrated a significant increase in symptoms of loneliness among residents as the pandemic progressed, with those unable to leave their room particularly vulnerable.197 Similar findings from a Swiss study note the increased prevalence of subjective loneliness of residents in long-term care during the pandemic,198 whereas a focus group study in Belgium noted loss of freedom, social life, autonomy, and recreational activities, impacting the basic psychological needs of residents.199 Both the pandemic and strict lockdown measures have had a demonstrable impact on the mental health and well-being of nursing home residents. The exact impact of this is yet to be fully elucidated.

Psychological Impact on Families

As a result of strict lockdowns, many jurisdictions banned visits to nursing homes, with a substantial impact on both residents and families. Once visits were allowed, in many cases they were only allowed in the context of outdoor visits, with minimal contact and contact precautions in place.200 Qualitative research from caregivers noted feelings related to physical separation, the inability of some individuals with cognitive impairment or dementia to understand the nature and rationale for visitation restrictions, and the need to stay connected to maintain the emotional and mental well-being of visitors.201 Similarly, data from the Engaging Remotely in Care (ERiC) Study demonstrated low psychological and emotional well-being during the COVID-19 lockdown in previously regular visitors of residents, particularly evident among visitors of those with cognitive impairment.9 For instance, in the ERiC study, visitors of those with cognitive impairment reported lower psychological and emotional well-being as measured using the WHO-5 well-being index.

Other studies have highlighted the importance of synchronous and familiar methods of communication such as telephone or email to maintain well-being in times of restrictions,202 and indeed a systematic review recommends increased use of information and communication technologies, family support groups, and the assignment of reference staff to each family.203 Increasing the number of communication options, frequency of communication, and increased context-specific information has been emphasized to increase the satisfaction of communication during visitation bans in Dutch nursing homes.204 Despite the impact of visiting restrictions on family members, most reported acceptance of visitation restriction policies.205 However, the impact on visitors was particularly striking for individuals approaching end of life, where visitation bans and potential issues with communication may add to significant individual distress.206

Psychological Impacts on Nursing Home Staff

Working during the pandemic has undoubtedly had a profound impact on care home staff. Nursing home staff working through the pandemic reported high levels of posttraumatic stress, mood disturbance, and moral injury.10 Important exacerbating factors included social pressure from work, increase in working hours, high exposure to suffering, lack of personal protective equipment, staff shortages, and minimal senior support.207 Similarly, lack of organizational support and a staff voice has been linked to increased perceptions of stress and anxiety in some nursing homes.208 However, in the same cohorts, the importance of social support at work has been shown to promote professional satisfaction.209 Studies examining staff resignations highlight the importance of effective employer communication, particularly in emergencies,210 and an increased focus on communication and support, with access to mental health support, for nursing home staff is imperative at an organizational level.211 Importantly, issues around low wages and lack of financial incentives may need to be resolved in order to attract and retain additional staff within the sector.211

Implications for Practice, Policy, and Research

In the nursing home sector, quick adaptation in many (such as adaptation of infection prevention and control measures and the availability and use of personal protective equipment) resulted in a decrease in overall infection rates and deaths from COVID-19. However, the striking impact of the first wave swiftly demonstrated how ill equipped nursing homes were to contain the outbreak.212 , 213 Nursing home residents represented between one-third and more than one-half of all nursing home deaths during the early waves of the pandemic and represent the group in society with the largest number of deaths from COVID-19 illness.

Following the early waves of the pandemic, both wider societal measures and those in nursing homes resulted in a decrease in the number of infections and deaths throughout much of 2020. Following the development and successful rollout of mass vaccination strategies, infections and deaths in nursing homes sharply declined; however, breakthrough infections, particularly with variants of concern, represent an ongoing concern for the sector. Importantly, risk factors for infections and outbreaks in nursing homes include SARS-CoV-2 community-transmission levels, nursing home size, quality and for-profit status, and wider societal measures. A wealth of high-quality evidence has emerged to support the effectiveness of both primary vaccination and vaccine booster doses in this group. Despite this, vaccine efficacy may wane over time and ongoing monitoring of infection levels and vaccine efficacy, particularly in the face of circulating variants of concern, is of crucial public health importance for the sector.

The sheer number of infections, outbreaks, and deaths experienced in nursing homes represented a significant challenge for the nursing home sector, one that has never been experienced. The unanticipated pandemic has indirectly laid bare several important deficiencies in the nursing home sector—for instance the lack of universal adoption of standards and quality improvement in the sector.214 , 215 Importantly, the pandemic highlighted the imperative quality improvement needed in the nursing home sector and the need to invest in a safe and effective long-term care sector into the future.

Important issues facing long-term care into the future include ensuring (1) recruitment and retainment of a well-trained, geriatric medicine–attuned workforce; (2) adequate investment, financing, and regulation of the sector; (3) the coordination of many complex aspects of primary, secondary and multidisciplinary care within nursing homes; (4) optimal chronic disease and scheduled routine medical care (including vaccinations); (5) specialist input from geriatric medicine, psychiatry, and palliative medicine services; and (6) review of architectural design principles of nursing homes.214 Importantly, many of these echo previous international guidance, including calls for universal adoption for standards of medical care by the European Geriatric Medicine Society in addition to position papers from the American Medical Directors Association (AMDA) and a recent report from the US National Academies of Science, Engineering, and Medicine.53 , 216 , 217 Although a discussion on these standards and their implementation is beyond the scope of the current review, the COVID-19 pandemic has highlighted important deficiencies in the long-term care sector, necessitating the need for a reimagination in the provision of high-quality long-term care as we move forward.218 , 219

Acknowledgments

The authors acknowledge the Meath Foundation and all staff at the Department of Age-Related Healthcare, Tallaght University Hospital, Dublin, Ireland.

Footnotes

Funding (AHD/NMB/SPK) was received by a COVID-19 rapid response grant from the Meath Foundation, Tallaght University Hospital. A.H.D. has been awarded the Irish Clinical Academic Training (ICAT) Programme, supported by the Wellcome Trust and the Health Research Board (Grant Number 203930/B/16/Z), the Health Service Executive, National Doctors Training and Planning, and the Health and Social Care, Research and Development Division, Northern Ireland. N.B. is funded under the Science Foundation Ireland Phase 2 COVID-19 Rapid Response Call (20/COV/8487) and the Health Research Board COVID-19 Rapid Response Call (COV19-2020-053). C.O.F. is supported by a Science Foundation Ireland Investigator Award (12/IA/1667) and under the Science Foundation Ireland Phase 2 Rapid Response Call (20/COV/8487). D.O.N. is funded under the Science Foundation Ireland Phase 2 COVID-19 Rapid Response Call (20/COV/8554).

The authors declare no conflicts of interest.

References

  • 1.Gordon A.L., Goodman C., Achterberg W., et al. Commentary: COVID in care homes-challenges and dilemmas in healthcare delivery. Age Ageing. 2020;49:701–705. doi: 10.1093/ageing/afaa113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Fallon A., Dukelow T., Kennelly S.P., et al. COVID-19 in nursing homes. QJM. 2020;113:391–392. doi: 10.1093/qjmed/hcaa136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Falconer M., O'Neill D. Profiling disability within nursing homes: a census-based approach. Age Ageing. 2007;36:209–213. doi: 10.1093/ageing/afl185. [DOI] [PubMed] [Google Scholar]
  • 4.Briggs R., Coughlan T., Collins R., et al. Nursing home residents attending the emergency department: clinical characteristics and outcomes. QJM. 2013;106:803–808. doi: 10.1093/qjmed/hct136. [DOI] [PubMed] [Google Scholar]
  • 5.O'Neill D. Covid-19 in care homes: the many determinants of this perfect storm. BMJ. 2020;369:m2096. doi: 10.1136/bmj.m2096. [DOI] [PubMed] [Google Scholar]
  • 6.Aalto U.L., Pitkälä K.H., Andersen-Ranberg K., et al. COVID-19 pandemic and mortality in nursing homes across USA and Europe up to October 2021. Eur Geriatr Med. 2022;13:705–709. doi: 10.1007/s41999-022-00637-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Schultze A., Nightingale E., Evans D., et al. Mortality among care home residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65. Lancet Reg Health Eur. 2022;14:100295. doi: 10.1016/j.lanepe.2021.100295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Checkland C., Benjamin S., Bruneau M.A., et al. Position statement for mental health care in long-term care during COVID-19. Can Geriatr J. 2021;24:367–372. doi: 10.5770/cgj.24.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.O'Caoimh R., O'Donovan M.R., Monahan M.P., et al. Psychosocial impact of COVID-19 nursing home restrictions on visitors of residents with cognitive impairment: a cross-sectional study as part of the Engaging Remotely in Care (ERiC) project. Front Psychiatry. 2020;11:585373. doi: 10.3389/fpsyt.2020.585373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Brady C., Fenton C., Loughran O., et al. Nursing home staff mental health during the Covid-19 pandemic in the Republic of Ireland. Int J Geriatr Psychiatry. November 2, 2021 doi: 10.1002/gps.5648. 10.1002/gps.5648 Published online November 2, 2021. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Muhsen K., Maimon N., Mizrahi A., et al. Effects of BNT162b2 Covid-19 vaccine booster in long-term care facilities in Israel. N Engl J Med. 2022;386:399–401. doi: 10.1056/NEJMc2117385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Shrotri M., Krutikov M., Nacer-Laidi H., et al. Duration of vaccine effectiveness against SARS-CoV2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study. Lancet Healthy Longev. 2022;3:e470–e480. doi: 10.1016/S2666-7568(22)00147-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Blain H., Rolland Y., Benetos A., et al. Atypical clinical presentation of COVID-19 infection in residents of a long-term care facility. Eur Geriatr Med. 2020;11:1085–1088. doi: 10.1007/s41999-020-00352-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Blain H., Gamon L., Tuaillon E., et al. Atypical symptoms, SARS-CoV-2 test results and immunisation rates in 456 residents from eight nursing homes facing a COVID-19 outbreak. Age Ageing. 2021;50:641–648. doi: 10.1093/ageing/afab050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rawle M.J., Bertfield D.L., Brill S.E. Atypical presentations of COVID-19 in care home residents presenting to secondary care: A UK single centre study. Aging Med (Milton) 2020;3:237–244. doi: 10.1002/agm2.12126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kennelly S.P., Dyer A.H., Noonan C., et al. Asymptomatic carriage rates and case fatality of SARS-CoV-2 infection in residents and staff in Irish nursing homes. Age Ageing. 2021;50:49–54. doi: 10.1093/ageing/afaa220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Borras-Bermejo B., Martínez-Gómez X., San Miguel M.G., et al. Asymptomatic SARS-CoV-2 Infection in Nursing Homes, Barcelona, Spain, April 2020. Emerg Infect Dis. 2020;26:2281–2283. doi: 10.3201/eid2609.202603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Meis-Pinheiro U., Lopez-Segui F., Walsh S., et al. Clinical characteristics of COVID-19 in older adults. A retrospective study in long-term nursing homes in Catalonia. PLoS One. 2021;16:e0255141. doi: 10.1371/journal.pone.0255141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Feaster M., Goh Y.Y. High proportion of asymptomatic SARS-CoV-2 infections in 9 long-term care facilities, Pasadena, California, USA, April 2020. Emerg Infect Dis. 2020;26:2416–2419. doi: 10.3201/eid2610.202694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Arons M.M., Hatfield K.M., Reddy S.C., et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. 2020;382:2081–2090. doi: 10.1056/NEJMoa2008457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kimball A., Hatfield K.M., Arons M., et al. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility - King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:377–381. doi: 10.15585/mmwr.mm6913e1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Burton J.K., McMinn M., Vaughan J.E., et al. Care-home outbreaks of COVID-19 in Scotland March to May 2020: national linked data cohort analysis. Age Ageing. 2021;50:1482–1492. doi: 10.1093/ageing/afab099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dutey-Magni P.F., Williams H., Jhass A., et al. COVID-19 infection and attributable mortality in UK care homes: cohort study using active surveillance and electronic records (March-June 2020) Age Ageing. 2021;50:1019–1028. doi: 10.1093/ageing/afab060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.White E.M., Kosar C.M., Feifer R.A., et al. Variation in SARS-CoV-2 prevalence in U.S. skilled nursing facilities. J Am Geriatr Soc. 2020;68:2167–2173. doi: 10.1111/jgs.16752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Rabilloud M., Riche B., Etard J.F., et al. COVID-19 outbreaks in nursing homes: A strong link with the coronavirus spread in the surrounding population, France, March to July 2020. PLoS One. 2022;17:e0261756. doi: 10.1371/journal.pone.0261756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Giddings R., Krutikov M., Palmer T., et al. Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021. Euro Surveill. 2021;26:2100995. doi: 10.2807/1560-7917.ES.2021.26.46.2100995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Suwono B., Steffen A., Schweickert B., et al. SARS-CoV-2 outbreaks in hospitals and long-term care facilities in Germany: a national observational study. Lancet Reg Health Eur. 2022;14:100303. doi: 10.1016/j.lanepe.2021.100303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Krutikov M., Palmer T., Tut G., et al. Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study. Lancet Healthy Longev. 2021;2:e362–e370. doi: 10.1016/S2666-7568(21)00093-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Krutikov M., Palmer T., Tut G., et al. Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England. Lancet Healthy Longev. 2022;3:e13–e21. doi: 10.1016/S2666-7568(21)00282-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Allen N., Brady M., Carrion Martin A.I., et al. Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals. J Infect. 2021;83:e9–e10. doi: 10.1016/j.jinf.2021.08.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Akinbami L.J., Biggerstaff B.J., Chan P.A., et al. Reinfection with SARS-CoV-2 among previously infected healthcare personnel and first responders. Clin Infect Dis. 2022;75:e201–e207. doi: 10.1093/cid/ciab952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Burugorri-Pierre C., Lafuente-Lafuente C., Oasi C., et al. Investigation of an outbreak of COVID-19 in a French nursing home with most residents vaccinated. JAMA Netw Open. 2021;4:e2125294. doi: 10.1001/jamanetworkopen.2021.25294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Cavanaugh A.M., Thoroughman D., Miranda H., et al. Suspected recurrent SARS-CoV-2 infections among residents of a skilled nursing facility during a second COVID-19 outbreak - Kentucky, July-November 2020. MMWR Morb Mortal Wkly Rep. 2021;70:273–277. doi: 10.15585/mmwr.mm7008a3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Faggiano F., Rossi M.A., Cena T., et al. An outbreak of COVID-19 among mRNA-vaccinated nursing home residents. Vaccines (Basel) 2021;9:859. doi: 10.3390/vaccines9080859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Martinot M., Carnein S., Kempf C., et al. Outbreak of SARS-CoV-2 infection in a long-term care facility after COVID-19 BNT162b2 mRNA vaccination. Clin Microbiol Infect. 2021;27:1537–1539. doi: 10.1016/j.cmi.2021.06.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Westhölter D., Taube C. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in a long-term care facility after vaccination with BNT162b2. Clin Infect Dis. 2021;73:2147–2148. doi: 10.1093/cid/ciab299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.White E.M., Yang X., Blackman C., et al. Incident SARS-CoV-2 infection among mRNA-vaccinated and unvaccinated nursing home residents. N Engl J Med. 2021;385:474–476. doi: 10.1056/NEJMc2104849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Suetens C., Kinross P., Gallego Berciano P., et al. Increasing risk of breakthrough COVID-19 in outbreaks with high attack rates in European long-term care facilities, July to October 2021. Euro Surveill. 2021;26:2101070. doi: 10.2807/1560-7917.ES.2021.26.49.2101070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Rivasi G., Bulgaresi M., Mossello E., et al. Course and lethality of SARS-CoV-2 epidemic in nursing homes after vaccination in Florence, Italy. Vaccines (Basel) 2021;9:1174. doi: 10.3390/vaccines9101174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Teran R.A., Walblay K.A., Shane E.L., et al. Postvaccination SARS-CoV-2 infections among skilled nursing facility residents and staff members - Chicago, Illinois, December 2020-March 2021. Am J Transplant. 2021;21:2290–2297. doi: 10.1111/ajt.16634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Bart S.M., Harizaj A., Pearson C.L., et al. SARS-CoV-2 Delta outbreak among fully vaccinated nursing home residents likely initiated by a fully vaccinated staff member - Connecticut, July-August 2021. Clin Infect Dis. 2022;75:e909–e911. doi: 10.1093/cid/ciab1025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Pierobon A., Zotto A.D., Antico A., et al. Outbreak of SARS-CoV-2 B.1.617.2 (delta) variant in a nursing home 28 weeks after two doses of mRNA anti-COVID-19 vaccines: evidence of a waning immunity. Clin Microbiol Infect. 2021;28:614.e5–614.e7. doi: 10.1016/j.cmi.2021.12.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Campos K.R., Sacchi C.T., Abbud A., et al. SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil. Rev Panam Salud Publica. 2021;45:e126. doi: 10.26633/RPSP.2021.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Williams C., Al-Bargash D., Macalintal C., et al. COVID-19 outbreak associated with a SARS-CoV-2 P.1 lineage in a long-term care home after implementation of a vaccination program - Ontario, April-May 2021. Clin Infect Dis. 2022;74:1085–1088. doi: 10.1093/cid/ciab617. [DOI] [PubMed] [Google Scholar]
  • 45.Krutikov M., Hayward A., Shallcross L. Spread of a variant SARS-CoV-2 in long-term care facilities in England. N Engl J Med. 2021;384:1671–1673. doi: 10.1056/NEJMc2035906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Mateos-Nozal J., Galán Montemayor J.C., Lores Torres S., et al. SARS-CoV-2 B 1.1.7 variant outbreak in a fully vaccinated nursing Home-Madrid, June 2021. J Am Med Dir Assoc. 2021;22:2266–2268. doi: 10.1016/j.jamda.2021.08.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lefèvre B., Tondeur L., Madec Y., et al. Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France. Lancet Healthy Longev. 2021;2:e685–e687. doi: 10.1016/S2666-7568(21)00230-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Vanker A., McGeer A., O'Byrne G., et al. Adverse outcomes associated with SARS-CoV-2 variant B.1.351 infection in vaccinated residents of a long term care home, Ontario, Canada. Clin Infect Dis. 2022;74:751–752. doi: 10.1093/cid/ciab523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Eggink D., Andeweg S.P., Vennema H., et al. Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022. Euro Surveill. 2022;27:2101196. doi: 10.2807/1560-7917.ES.2022.27.4.2101196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Veneti L., Bøås H., Bråthen Kristoffersen A., et al. Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022. Euro Surveill. 2022;27:2200077. doi: 10.2807/1560-7917.ES.2022.27.4.2200077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Lee D.S., Wang C.X., McAlister F.A., et al. Factors associated with SARS-CoV-2 test positivity in long-term care homes: a population-based cohort analysis using machine learning. Lancet Reg Health Am. 2022;6:100146. doi: 10.1016/j.lana.2021.100146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Konetzka R.T., White E.M., Pralea A., et al. A systematic review of long-term care facility characteristics associated with COVID-19 outcomes. J Am Geriatr Soc. 2021;69:2766–2777. doi: 10.1111/jgs.17434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Abrams H.R., Loomer L., Gandhi A., et al. Characteristics of U.S. nursing homes with COVID-19 cases. J Am Geriatr Soc. 2020;68:1653–1656. doi: 10.1111/jgs.16661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Cazzoletti L., Zanolin M.E., Tocco Tussardi I., et al. Risk factors associated with nursing home COVID-19 outbreaks: a retrospective cohort study. Int J Environ Res Public Health. 2021;18:8434. doi: 10.3390/ijerph18168434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Costa A.P., Manis D.R., Jones A., et al. Risk factors for outbreaks of SARS-CoV-2 infection at retirement homes in Ontario, Canada: a population-level cohort study. CMAJ. 2021;193:e672–e680. doi: 10.1503/cmaj.202756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Zimmerman S., Dumond-Stryker C., Tandan M., et al. Nontraditional small house nursing homes have fewer COVID-19 cases and deaths. J Am Med Dir Assoc. 2021;22:489–493. doi: 10.1016/j.jamda.2021.01.069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Piet E., Maillard A., Mallaval F.O., et al. Outbreaks of COVID-19 in nursing homes: a cross-sectional survey of 74 nursing homes in a French Area. J Clin Med. 2021;10:4280. doi: 10.3390/jcm10184280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.McGarry B.E., Gandhi A.D., Grabowski D.C., et al. Larger nursing home staff size linked to higher number of COVID-19 cases in 2020. Health Aff (Millwood) 2021;40:1261–1269. doi: 10.1377/hlthaff.2021.00323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Gorges R.J., Konetzka R.T. Staffing levels and COVID-19 cases and outbreaks in U.S. nursing homes. J Am Geriatr Soc. 2020;68:2462–2466. doi: 10.1111/jgs.16787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Shallcross L., Burke D., Abbott O., et al. Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey. Lancet Healthy Longev. 2021;2:e129–e142. doi: 10.1016/S2666-7568(20)30065-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Bowblis J., Applebaum R. Prevalence of COVID-19 in Ohio nursing homes: what's quality got to do with it? J Aging Soc Policy. 2021;33:414–430. doi: 10.1080/08959420.2020.1824542. [DOI] [PubMed] [Google Scholar]
  • 62.Bui D.P., See I., Hesse E.M., et al. Association between CMS quality ratings and COVID-19 outbreaks in nursing homes - West Virginia, March 17-June 11, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1300–1304. doi: 10.15585/mmwr.mm6937a5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Gopal R., Han X., Yaraghi N. Compress the curve: a cross-sectional study of variations in COVID-19 infections across California nursing homes. BMJ Open. 2021;11:e042804. doi: 10.1136/bmjopen-2020-042804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.He M., Li Y., Fang F. Is there a link between nursing home reported quality and COVID-19 cases? Evidence from California skilled nursing facilities. J Am Med Dir Assoc. 2020;21:905–908. doi: 10.1016/j.jamda.2020.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Khairat S., Zalla L.C., Adler-Milstein J., et al. U.S. Nursing home quality ratings associated with COVID-19 cases and deaths. J Am Med Dir Assoc. 2021;22:2021–2025.e2021. doi: 10.1016/j.jamda.2021.07.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Rosenberg K. More nursing home staff linked to more COVID-19 cases. Am J Nurs. 2021;121:69. doi: 10.1097/01.NAJ.0000799036.98380.41. [DOI] [PubMed] [Google Scholar]
  • 67.Williams C.S., Zheng Q., White A.J., et al. The association of nursing home quality ratings and spread of COVID-19. J Am Geriatr Soc. 2021;69:2070–2078. doi: 10.1111/jgs.17309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Figueroa J.F., Wadhera R.K., Papanicolas I., et al. Association of nursing home ratings on health inspections, quality of care, and nurse staffing with COVID-19 cases. JAMA. 2020;324:1103–1105. doi: 10.1001/jama.2020.14709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Anderson D.C., Grey T., Kennelly S., et al. Nursing home design and COVID-19: balancing infection control, quality of life, and resilience. J Am Med Dir Assoc. 2020;21:1519–1524. doi: 10.1016/j.jamda.2020.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Akhtar-Danesh N., Baumann A., Crea-Arsenio M., et al. COVID-19 excess mortality among long-term care residents in Ontario, Canada. PLoS One. 2022;17:e0262807. doi: 10.1371/journal.pone.0262807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Alacevich C., Cavalli N., Giuntella O., et al. The presence of care homes and excess deaths during the COVID-19 pandemic: evidence from Italy. Health Econ. 2021;30:1703–1710. doi: 10.1002/hec.4277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Bielza R., Sanz J., Zambrana F., et al. Clinical characteristics, frailty, and mortality of residents with COVID-19 in nursing homes of a region of Madrid. J Am Med Dir Assoc. 2021;22:245–252.e242. doi: 10.1016/j.jamda.2020.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Burki T. England and Wales see 20 000 excess deaths in care homes. Lancet. 2020;395:1602. doi: 10.1016/S0140-6736(20)31199-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Canouï-Poitrine F., Rachas A., Thomas M., et al. Magnitude, change over time, demographic characteristics and geographic distribution of excess deaths among nursing home residents during the first wave of COVID-19 in France: a nationwide cohort study. Age Ageing. 2021;50:1473–1481. doi: 10.1093/ageing/afab098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Morciano M., Stokes J., Kontopantelis E., et al. Excess mortality for care home residents during the first 23 weeks of the COVID-19 pandemic in England: a national cohort study. BMC Med. 2021;19:71. doi: 10.1186/s12916-021-01945-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Hollinghurst J., Lyons J., Fry R., et al. The impact of COVID-19 on adjusted mortality risk in care homes for older adults in Wales, UK: a retrospective population-based cohort study for mortality in 2016-2020. Age Ageing. 2021;50:25–31. doi: 10.1093/ageing/afaa207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Leão T., Severo M., Barros H. COVID-19 transmission and case fatality in long-term care facilities during the epidemic first wave. J Am Geriatr Soc. 2021;69:3399–3401. doi: 10.1111/jgs.17427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Shen K., Loomer L., Abrams H., et al. Estimates of COVID-19 cases and deaths among nursing home residents not reported in federal data. JAMA Netw Open. 2021;4:e2122885. doi: 10.1001/jamanetworkopen.2021.22885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.White E.M. Underreporting of early nursing home COVID-19 cases and deaths in federal data. JAMA Netw Open. 2021;4:e2123696. doi: 10.1001/jamanetworkopen.2021.23696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Gomolin I.H., Hartley D.A., Polsky B. Post-acute care nursing home deaths in the COVID era: potential for attribution bias. J Am Geriatr Soc. 2021;69:1450–1452. doi: 10.1111/jgs.17132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Kosar C.M., White E.M., Feifer R.A., et al. COVID-19 mortality rates among nursing home residents declined from March to November 2020. Health Aff (Millwood) 2021;40:655–663. doi: 10.1377/hlthaff.2020.02191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Ballin M., Bergman J., Kivipelto M., et al. Excess mortality after COVID-19 in Swedish long-term care facilities. J Am Med Dir Assoc. 2021;22:1574–1580.e1578. doi: 10.1016/j.jamda.2021.06.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Cangiano B., Fatti L.M., Danesi L., et al. Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests. Aging (Albany NY) 2020;12:24522–24534. doi: 10.18632/aging.202307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.España P.P., Bilbao A., García-Gutiérrez S., et al. Predictors of mortality of COVID-19 in the general population and nursing homes. Intern Emerg Med. 2021;16:1487–1496. doi: 10.1007/s11739-020-02594-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.García-Cabrera L., Pérez-Abascal N., Montero-Errasquín B., et al. Characteristics, hospital referrals and 60-day mortality of older patients living in nursing homes with COVID-19 assessed by a liaison geriatric team during the first wave: a research article. BMC Geriatr. 2021;21:610. doi: 10.1186/s12877-021-02565-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Heras E., Garibaldi P., Boix M., et al. COVID-19 mortality risk factors in older people in a long-term care center. Eur Geriatr Med. 2021;12:601–607. doi: 10.1007/s41999-020-00432-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Couderc A.L., Correard F., Hamidou Z., et al. Factors associated with COVID-19 hospitalizations and deaths in French nursing homes. J Am Med Dir Assoc. 2021;22:1581–1587.e1583. doi: 10.1016/j.jamda.2021.06.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Burgaña Agoües A., Serra Gallego M., Hernández Resa R., et al. Risk factors for COVID-19 morbidity and mortality in institutionalised elderly people. Int J Environ Res Public Health. 2021;18:10221. doi: 10.3390/ijerph181910221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.De Vito A., Fiore V., Princic E., et al. Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes. PLoS One. 2021;16:e0248009. doi: 10.1371/journal.pone.0248009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Rutten J.J.S., van Kooten J., van Loon A.M., et al. Dementia and Parkinson's disease: risk factors for 30-day mortality in nursing home residents with COVID-19. J Alzheimers Dis. 2021;84:1173–1181. doi: 10.3233/JAD-210319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Thorsness R., Raines N.H., White E.M., et al. Association of kidney function with 30-day mortality following SARS-CoV-2 infection in nursing home residents: a retrospective cohort study. Am J Kidney Dis. 2022;79:305–307. doi: 10.1053/j.ajkd.2021.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Lee D.S., Ma S., Chu A., et al. Predictors of mortality among long-term care residents with SARS-CoV-2 infection. J Am Geriatr Soc. 2021;69:3377–3388. doi: 10.1111/jgs.17425. [DOI] [PubMed] [Google Scholar]
  • 93.Panagiotou O.A., Kosar C.M., White E.M., et al. Risk factors associated with all-cause 30-day mortality in nursing home residents with COVID-19. JAMA Intern Med. 2021;181:439–448. doi: 10.1001/jamainternmed.2020.7968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Ramos-Rincón J.M., Bernabeu-Whittel M., Fiteni-Mera I., et al. Clinical features and risk factors for mortality among long-term care facility residents hospitalized due to COVID-19 in Spain. J Gerontol A Biol Sci Med Sci. 2022;77:e138–e147. doi: 10.1093/gerona/glab305. [DOI] [PubMed] [Google Scholar]
  • 95.Trecarichi E.M., Mazzitelli M., Serapide F., et al. Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility. Sci Rep. 2020;10:20834. doi: 10.1038/s41598-020-77641-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Cai S., Yan D., Intrator O. COVID-19 cases and death in nursing homes: the role of racial and ethnic composition of facilities and their communities. J Am Med Dir Assoc. 2021;22:1345–1351. doi: 10.1016/j.jamda.2021.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Gorges R.J., Konetzka R.T. Factors associated with racial differences in deaths among nursing home residents with COVID-19 infection in the US. JAMA Netw Open. 2021;4:e2037431. doi: 10.1001/jamanetworkopen.2020.37431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Li Y., Temkin-Greener H., Shan G., et al. COVID-19 infections and deaths among connecticut nursing home residents: facility correlates. J Am Geriatr Soc. 2020;68:1899–1906. doi: 10.1111/jgs.16689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Bach-Mortensen A.M., Degli Esposti M. Is area deprivation associated with greater impacts of COVID-19 in care homes across England? A preliminary analysis of COVID-19 outbreaks and deaths. J Epidemiol Community Health. February 8, 2021 doi: 10.1136/jech-2020-215039. 10.1136/jech-2020-215039 Published online February 8, 2021. doi: [DOI] [PubMed] [Google Scholar]
  • 100.Unruh M.A., Yun H., Zhang Y., et al. Nursing home characteristics associated with COVID-19 deaths in Connecticut, New Jersey, and New York. J Am Med Dir Assoc. 2020;21:1001–1003. doi: 10.1016/j.jamda.2020.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Gandhi M., Yokoe D.S., Havlir D.V. Asymptomatic transmission, the Achilles' heel of current strategies to control Covid-19. N Engl J Med. 2020;382:2158–2160. doi: 10.1056/NEJMe2009758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Goldberg S.A., Lennerz J., Klompas M., et al. Presymptomatic transmission of severe acute respiratory syndrome coronavirus 2 among residents and staff at a skilled nursing facility: results of real-time polymerase chain reaction and serologic testing. Clin Infect Dis. 2021;72:686–689. doi: 10.1093/cid/ciaa991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Sethuraman N., Jeremiah S.S., Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA. 2020;323:2249–2251. doi: 10.1001/jama.2020.8259. [DOI] [PubMed] [Google Scholar]
  • 104.Love J., Wimmer M.T., Toth D.J.A., et al. Comparison of antigen- and RT-PCR-based testing strategies for detection of SARS-CoV-2 in two high-exposure settings. PLoS One. 2021;16:e0253407. doi: 10.1371/journal.pone.0253407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Blain H., Rolland Y., Tuaillon E., et al. Efficacy of a test-retest strategy in residents and health care personnel of a nursing home facing a COVID-19 outbreak. J Am Med Dir Assoc. 2020;21:933–936. doi: 10.1016/j.jamda.2020.06.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Armstrong J.N., Campbell L., Rabatsky-Her T., et al. Repeat positive SARS-CoV-2 RNA testing in nursing home residents during the initial 9 months of the COVID-19 pandemic: an observational retrospective analysis. Lancet Reg Health Am. 2021;3:100054. doi: 10.1016/j.lana.2021.100054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Surie D., Huang J.Y., Brown A.C., et al. Infectious period of severe acute respiratory syndrome coronavirus 2 in 17 nursing home residents—Arkansas, June-August 2020. Open Forum Infect Dis. 2021;8:ofab048. doi: 10.1093/ofid/ofab048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Dora A.V., Winnett A., Jatt L.P., et al. Universal and serial laboratory testing for SARS-CoV-2 at a long-term care skilled nursing facility for Veterans—Los Angeles, California, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:651–655. doi: 10.15585/mmwr.mm6921e1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Barker R.O., Astle A., Spilsbury K., et al. COVID-19 testing during care home outbreaks: the more the better? Age Ageing. 2021;50:1433–1435. doi: 10.1093/ageing/afab100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Bigelow B.F., Tang O., Barshick B., et al. Outcomes of Universal COVID-19 testing following detection of incident cases in 11 long-term care facilities. JAMA Intern Med. 2021;181:127–129. doi: 10.1001/jamainternmed.2020.3738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Birgand G., Blanckaert K., Deschanvres C., et al. Testing strategies for the control of COVID-19 in nursing homes: universal or targeted screening? J Infect. 2021;82:159–198. doi: 10.1016/j.jinf.2020.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Escobar D.J., Lanzi M., Saberi P., et al. Mitigation of a coronavirus disease 2019 outbreak in a nursing home through serial testing of residents and staff. Clin Infect Dis. 2021;72:e394–e396. doi: 10.1093/cid/ciaa1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Louie J.K., Scott H.M., DuBois A., et al. Lessons from mass-testing for coronavirus disease 2019 in long-term care facilities for the elderly in San Francisco. Clin Infect Dis. 2021;72:2018–2020. doi: 10.1093/cid/ciaa1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Sanchez G.V., Biedron C., Fink L.R., et al. Initial and repeated point prevalence surveys to inform SARS-CoV-2 infection prevention in 26 skilled nursing facilities - Detroit, Michigan, March-May 2020. MMWR Morb Mortal Wkly Rep. 2020;69:882–886. doi: 10.15585/mmwr.mm6927e1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.See I., Paul P., Slayton R.B., et al. Modeling effectiveness of testing strategies to prevent coronavirus disease 2019 (COVID-19) in nursing homes-United States, 2020. Clin Infect Dis. 2021;73:e792–e798. doi: 10.1093/cid/ciab110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.McKay S.L., Tobolowsky F.A., Moritz E.D., et al. Performance evaluation of serial SARS-CoV-2 rapid antigen testing during a nursing home outbreak. Ann Intern Med. 2021;174:945–951. doi: 10.7326/M21-0422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Moritz E.D., McKay S.L., Tobolowsky F.A., et al. Repeated antigen testing among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive nursing home residents. Infect Control Hosp Epidemiol. August 20, 2021 doi: 10.1017/ice.2021.370. 10.1017/ice.2021.370 Published online August 20, 2021. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Bej T., Kothadia S., Wilson B.M., et al. Impact of fever thresholds in detection of COVID-19 in Department of Veterans Affairs Community Living Center residents. J Am Geriatr Soc. 2021;69:3044–3050. doi: 10.1111/jgs.17415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.McConeghy K.W., White E., Panagiotou O.A., et al. Temperature Screening for SARS-CoV-2 in nursing homes: evidence from two national cohorts. J Am Geriatr Soc. 2020;68:2716–2720. doi: 10.1111/jgs.16876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Rudolph J.L., Halladay C.W., Barber M., et al. Temperature in nursing home residents systematically tested for SARS-CoV-2. J Am Med Dir Assoc. 2020;21:895–899.e891. doi: 10.1016/j.jamda.2020.06.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Frazer K., Mitchell L., Stokes D., et al. A rapid systematic review of measures to protect older people in long-term care facilities from COVID-19. BMJ Open. 2021;11:e047012. doi: 10.1136/bmjopen-2020-047012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Lipsitz L.A., Lujan A.M., Dufour A., et al. Stemming the tide of COVID-19 infections in Massachusetts nursing homes. J Am Geriatr Soc. 2020;68:2447–2453. doi: 10.1111/jgs.16832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Stratil J.M., Biallas R.L., Burns J., et al. Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review. Cochrane Database Syst Rev. 2021;9:Cd015085. doi: 10.1002/14651858.CD015085.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Rios P., Radhakrishnan A., Williams C., et al. Preventing the transmission of COVID-19 and other coronaviruses in older adults aged 60 years and above living in long-term care: a rapid review. Syst Rev. 2020;9:218. doi: 10.1186/s13643-020-01486-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Dufour A.B., Kosar C., Mor V., et al. The effect of race and dementia prevalence on a COVID-19 infection control intervention in Massachusetts nursing homes. J Gerontol A Biol Sci Med Sci. 2022;77:1361–1365. doi: 10.1093/gerona/glab355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.González de Villaumbrosia C., Martínez Peromingo J., Ortiz Imedio J., et al. Implementation of an algorithm of cohort classification to prevent the spread of COVID-19 in nursing homes. J Am Med Dir Assoc. 2020;21:1811–1814. doi: 10.1016/j.jamda.2020.10.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Kain D.C., McCreight L.J., Johnstone J. Dealing with coronavirus disease 2019 (COVID-19) outbreaks in long-term care homes: a protocol for room moving and cohorting. Infect Control Hosp Epidemiol. 2021;42:1402–1403. doi: 10.1017/ice.2020.1302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Krone M., Noffz A., Richter E., et al. Control of a COVID-19 outbreak in a nursing home by general screening and cohort isolation in Germany, March to May 2020. Euro Surveill. 2021;26:2001365. doi: 10.2807/1560-7917.ES.2021.26.1.2001365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Nguyen L.K.N., Howick S., McLafferty D., et al. Impact of visitation and cohorting policies to shield residents from covid-19 spread in care homes: an agent-based model. Am J Infect Control. 2021;49:1105–1112. doi: 10.1016/j.ajic.2021.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Telford C.T., Bystrom C., Fox T., et al. COVID-19 infection prevention and control adherence in long-term care facilities, Atlanta, Georgia. J Am Geriatr Soc. 2021;69:581–586. doi: 10.1111/jgs.17001. [DOI] [PubMed] [Google Scholar]
  • 131.Vogazianos P., Argyropoulos C.D., Haralambous C., et al. Impact assessment of COVID-19 non-pharmaceutical interventions in long term care facilities in Cyprus: safety improvement strategy. Saf Sci. 2021;143:105415. doi: 10.1016/j.ssci.2021.105415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Love J., Keegan L.T., Angulo F.J., et al. Continued need for non-pharmaceutical interventions after COVID-19 vaccination in long-term-care facilities. Sci Rep. 2021;11:18093. doi: 10.1038/s41598-021-97612-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Haegdorens F., Franck E., Smith P., et al. Sufficient personal protective equipment training can reduce COVID-19 related symptoms in healthcare workers: a prospective cohort study. Int J Nurs Stud. 2022;126:104132. doi: 10.1016/j.ijnurstu.2021.104132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Yang B., Huang A.T., Garcia-Carreras B., et al. Effect of specific non-pharmaceutical intervention policies on SARS-CoV-2 transmission in the counties of the United States. Nat Commun. 2021;12:3560. doi: 10.1038/s41467-021-23865-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Wingfield D., Taghavi Azar Sharabiani M., Majeed A., et al. Risk of COVID-19 in shielded and nursing care home patients: a cohort study in general practice. BJGP Open. 2021;5 doi: 10.3399/BJGPO.2021.0081. BJGPO.2021.0081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Bernabeu-Wittel M., Ternero-Vega J.E., Nieto-Martín M.D., et al. Effectiveness of a on-site medicalization program for nursing homes with COVID-19 outbreaks. J Gerontol A Biol Sci Med Sci. 2021;76:e19–e27. doi: 10.1093/gerona/glaa192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Montoya A., Jenq G., Mills J.P., et al. Partnering with local hospitals and public health to manage COVID-19 outbreaks in nursing homes. J Am Geriatr Soc. 2021;69:30–36. doi: 10.1111/jgs.16869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.van Tol L.S., Smaling H.J.A., Groothuijse J.M., et al. COVID-19 management in nursing homes by outbreak teams (MINUTES) - study description and data characteristics: a qualitative study. BMJ Open. 2021;11:e053235. doi: 10.1136/bmjopen-2021-053235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Coulongeat M., Aïdoud A., Poupin P., et al. A local COVID-19 support platform for nursing homes: feedback and perspectives. J Am Med Dir Assoc. 2021;22:1599–1601. doi: 10.1016/j.jamda.2021.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Poupin P., N'Diaye D., Chaumier F., et al. Management of COVID-19 in a French nursing home: experiences from a multidisciplinary mobile team. J Frailty Aging. 2021;10:363–366. doi: 10.14283/jfa.2021.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Groom L.L., McCarthy M.M., Stimpfel A.W., et al. Telemedicine and telehealth in nursing homes: an integrative review. J Am Med Dir Assoc. 2021;22:1784–1801.e1787. doi: 10.1016/j.jamda.2021.02.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Jen S.P., Bui A., Leonard S.D. Maximizing efficiency of telemedicine in the skilled nursing facility during the coronavirus disease 2019 pandemic. J Am Med Dir Assoc. 2021;22:1146–1148.e1142. doi: 10.1016/j.jamda.2021.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Petrazzuoli F., Kurpas D., Vinker S., et al. COVID-19 pandemic and the great impulse to telemedicine: the basis of the WONCA Europe statement on telemedicine at the WHO Europe 70th Regional Meeting September 2020. Prim Health Care Res Dev. 2021;22:e80. doi: 10.1017/S1463423621000633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Gibson D.M., Greene J. Admissions of COVID-positive patients to US nursing homes with personal protective equipment or staffing shortages. J Am Geriatr Soc. 2021;69:2393–2403. doi: 10.1111/jgs.17302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Spacey A., Porter S., Board M., et al. Impact of the COVID-19 pandemic on end of life care delivery in care homes: a mixed method systematic review. Palliat Med. 2021;35:1468–1479. doi: 10.1177/02692163211029806. [DOI] [PubMed] [Google Scholar]
  • 146.Strang P., Bergström J., Martinsson L., et al. Dying from COVID-19: loneliness, end-of-life discussions, and support for patients and their families in nursing homes and hospitals. A national register study. J Pain Symptom Manage. 2020;60:e2–e13. doi: 10.1016/j.jpainsymman.2020.07.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Grimm F., Hodgson K., Brine R., et al. Hospital admissions from care homes in England during the COVID-19 pandemic: a retrospective, cross-sectional analysis using linked administrative data. Int J Popul Data Sci. 2020;5:1663. doi: 10.23889/ijpds.v5i4.1663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Martinsson L., Strang P., Bergström J., et al. Were clinical routines for good end-of-life care maintained in hospitals and nursing homes during the first three months of the outbreak of COVID-19? A national register study. J Pain Symptom Manage. 2021;61:e11–e19. doi: 10.1016/j.jpainsymman.2020.09.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149.Ter Brugge B.P.H., van Atteveld V.A., Fleuren N., et al. Advance care planning in Dutch nursing homes during the first wave of the COVID-19 pandemic. J Am Med Dir Assoc. 2022;23:1–6.e1. doi: 10.1016/j.jamda.2021.10.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Harding A., Preston N., Doherty J., et al. Developing and evaluating online COVID-centric advance care planning training and information resources for nursing staff and family members in nursing homes: the necessary discussions study protocol. BMC Geriatr. 2021;21:456. doi: 10.1186/s12877-021-02398-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151.Berning M.J., Palmer E., Tsai T., et al. An advance care planning long-term care initiative in response to COVID-19. J Am Geriatr Soc. 2021;69:861–867. doi: 10.1111/jgs.17051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152.Cabezas C., Coma E., Mora-Fernandez N., et al. Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with COVID-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study. BMJ. 2021;374:n1868. doi: 10.1136/bmj.n1868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Shrotri M., Krutikov M., Palmer T., et al. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study. Lancet Infect Dis. 2021;21:1529–1538. doi: 10.1016/S1473-3099(21)00289-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154.Domi M., Leitson M., Gifford D., et al. The BNT162b2 vaccine is associated with lower new COVID-19 cases in nursing home residents and staff. J Am Geriatr Soc. 2021;69:2079–2089. doi: 10.1111/jgs.17224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Mazagatos C., Monge S., Olmedo C., et al. Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021. Euro Surveill. 2021;26:2100452. doi: 10.2807/1560-7917.ES.2021.26.24.2100452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Monge S., Olmedo C., Alejos B., et al. Direct and indirect effectiveness of mRNA vaccination against severe acute respiratory syndrome coronavirus 2 in long-term care facilities, Spain. Emerg Infect Dis. 2021;27:2595–2603. doi: 10.3201/eid2710.211184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 157.Mor V., Gutman R., Yang X., et al. Short-term impact of nursing home SARS-CoV-2 vaccinations on new infections, hospitalizations, and deaths. J Am Geriatr Soc. 2021;69:2063–2069. doi: 10.1111/jgs.17176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Pierobon S., Braggion M., Fedeli U., et al. Impact of vaccination on the spread of SARS-CoV-2 infection in north-east Italy nursing homes. A propensity score and risk analysis. Age Ageing. 2022;51:afab224. doi: 10.1093/ageing/afab224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.Salcher-Konrad M., Smith S., Comas-Herrera A. Emerging evidence on effectiveness of COVID-19 vaccines among residents of long-term care facilities. J Am Med Dir Assoc. 2021;22:1602–1603. doi: 10.1016/j.jamda.2021.05.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160.Nanduri S., Pilishvili T., Derado G., et al. Effectiveness of Pfizer-BioNTech and Moderna vaccines in preventing SARS-CoV-2 infection among nursing home residents before and during widespread circulation of the SARS-CoV-2 B.1.617.2 (Delta) variant - National Healthcare Safety Network, March 1-August 1, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1163–1166. doi: 10.15585/mmwr.mm7034e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Barda N., Dagan N., Cohen C., et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet. 2021;398:2093–2100. doi: 10.1016/S0140-6736(21)02249-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162.Blain H., Tuaillon E., Gamon L., et al. Spike antibody levels of nursing home residents with or without prior COVID-19 3 weeks after a single BNT162b2 vaccine dose. JAMA. 2021;325:1898–1899. doi: 10.1001/jama.2021.6042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 163.Dyer A.H., Noonan C., McElheron M., et al. Previous SARS-CoV-2 infection, age, and frailty are associated with 6-month vaccine-induced anti-spike antibody titer in nursing home residents. J Am Med Dir Assoc. 2022;23:434–439. doi: 10.1016/j.jamda.2021.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164.Blain H., Tuaillon E., Gamon L., et al. Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: the CONsort-19 study. Allergy. 2022;77:271–281. doi: 10.1111/all.15007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 165.Seiffert P., Konka A., Kasperczyk J., et al. Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in older residents of a long-term care facility: relation with age, frailty and prior infection status. Biogerontology. 2022;23:53–64. doi: 10.1007/s10522-021-09944-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166.Faro-Viana J., Bergman M.L., Gonçalves L.A., et al. Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges. Nat Commun. 2022;13:140. doi: 10.1038/s41467-021-27761-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167.Pannus P., Neven K.Y., De Craeye S., et al. Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes. Clin Infect Dis. 2022;75:e695–e704. doi: 10.1093/cid/ciab998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168.Causa R., Almagro-Nievas D., Rivera-Izquierdo M., et al. Antibody response 3 months after 2 doses of BNT162b2 mRNA COVID-19 vaccine in residents of long-term care facilities. Gerontology. 2022;68:910–916. doi: 10.1159/000519711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 169.Tanunliong G., Liu A., Vijh R., et al. Persistence of anti-SARS-CoV-2 antibodies in long term care residents over seven months after two COVID-19 outbreaks. Front Immunol. 2021;12:775420. doi: 10.3389/fimmu.2021.775420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170.Kolarić B., Ambriović-Ristov A., Tabain I., et al. Waning immunity six months after BioNTech/Pfizer COVID-19 vaccination among nursing home residents in Zagreb, Croatia. Croat Med J. 2021;62:630–633. doi: 10.3325/cmj.2021.62.630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171.Moyet J., Helle F., Bourdenet G., et al. Kinetics of SARS-CoV-2-neutralising antibodies of residents of long-term care facilities. J Nutr Health Aging. 2022;26:57–63. doi: 10.1007/s12603-021-1713-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 172.Salmerón Ríos S., Cortés Zamora E.B., Avendaño Céspedes A., et al. Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: the COVID-A study. J Am Geriatr Soc. 2022;70:650–658. doi: 10.1111/jgs.17620. [DOI] [PubMed] [Google Scholar]
  • 173.Helle F., Moyet J., Demey B., et al. Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status. Vaccine. 2022;40:531–535. doi: 10.1016/j.vaccine.2021.11.086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 174.Meijide Míguez H., Ochando Gómez M., Montes García I., et al. Cellular and humoral response, six months after two doses of BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccination, in residents and staff of nursing homes for the elderly. J Infect Dis. 2022;225:355–357. doi: 10.1093/infdis/jiab546. [DOI] [PubMed] [Google Scholar]
  • 175.Albert E., Burgos J.S., Peiró S., et al. Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents. Clin Microbiol Infect. 2022;28:279–284. doi: 10.1016/j.cmi.2021.09.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 176.Torres I., Albert E., Giménez E., et al. B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents. Clin Microbiol Infect. 2021;27:1672–1677. doi: 10.1016/j.cmi.2021.06.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 177.Van Praet J.T., Vandecasteele S., De Roo A., et al. Humoral and cellular immunogenicity of the BNT162b2 messenger RNA coronavirus disease 2019 vaccine in nursing home residents. Clin Infect Dis. 2021;73:2145–2147. doi: 10.1093/cid/ciab300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 178.Van Praet J.T., Vandecasteele S., De Roo A., et al. Dynamics of the cellular and humoral immune response after BNT162b2 mRNA Covid-19 vaccination in Covid-19 naive nursing home residents. J Infect Dis. September 13, 2021 doi: 10.1093/infdis/jiab458. 10.1093/infdis/jiab458 Published online September 13, 2021. doi: [DOI] [PubMed] [Google Scholar]
  • 179.Canaday D.H., Oyebanji O.A., White E., et al. Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination. medRxiv. 2021 doi: 10.1101/2021.12.07.21267179. [DOI] [Google Scholar]
  • 180.Blain H., Tuaillon E., Gamon L., et al. Receptor binding domain-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 outbreaks. Allergy. 2022;77:1885–1894. doi: 10.1111/all.15142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 181.McGarry B.E., Barnett M.L., Grabowski D.C., et al. Nursing home staff vaccination and Covid-19 outcomes. N Engl J Med. 2022;386:397–398. doi: 10.1056/NEJMc2115674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 182.Gharpure R., Guo A., Bishnoi C.K., et al. Early COVID-19 first-dose vaccination coverage among residents and staff members of skilled nursing facilities participating in the pharmacy partnership for long-term care program - United States, December 2020-January 2021. MMWR Morb Mortal Wkly Rep. 2021;70:178–182. doi: 10.15585/mmwr.mm7005e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 183.Gharpure R., Patel A., Link-Gelles R. First-dose COVID-19 vaccination coverage among skilled nursing facility residents and staff. JAMA. 2021;325:1670–1671. doi: 10.1001/jama.2021.2352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 184.Lee J.T., Althomsons S.P., Wu H., et al. Disparities in COVID-19 vaccination coverage among health care personnel working in long-term care facilities, by job category, National Healthcare Safety Network - United States, March 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1036–1039. doi: 10.15585/mmwr.mm7030a2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185.McGarry B.E., Shen K., Barnett M.L., et al. Association of nursing home characteristics with staff and resident COVID-19 vaccination coverage. JAMA Intern Med. 2021;181:1670–1672. doi: 10.1001/jamainternmed.2021.5890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 186.Dumyati G., Jump R.L.P., Gaur S. Mandating COVID-19 vaccine for nursing home staff: an ethical obligation. J Am Med Dir Assoc. 2021;22:1967–1968. doi: 10.1016/j.jamda.2021.08.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 187.Ritter A.Z., Kelly J., Kent R.M., et al. Implementation of a coronavirus disease 2019 vaccination condition of employment in a community nursing home. J Am Med Dir Assoc. 2021;22:1998–2002. doi: 10.1016/j.jamda.2021.07.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 188.Berry S.D., Baier R.R., Syme M., et al. Strategies associated with COVID-19 vaccine coverage among nursing home staff. J Am Geriatr Soc. 2022;70:19–28. doi: 10.1111/jgs.17559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 189.Harrison J., Berry S., Mor V., et al. "Somebody like me": understanding COVID-19 vaccine hesitancy among staff in skilled nursing facilities. J Am Med Dir Assoc. 2021;22:1133–1137. doi: 10.1016/j.jamda.2021.03.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 190.Berry S.D., Johnson K.S., Myles L., et al. Lessons learned from frontline skilled nursing facility staff regarding COVID-19 vaccine hesitancy. J Am Geriatr Soc. 2021;69:1140–1146. doi: 10.1111/jgs.17136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 191.Tylec A., Janiszewska M., Siejko K., et al. Determinants of the decision to be vaccinated against COVID-19 as exemplified by employees of a long-term health care centre. J Public Health (Oxf) December 21, 2021 doi: 10.1093/pubmed/fdab395. 10.1093/pubmed/fdab395 Published online December 21, 2021. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 192.Górski M., Buczkowska M., Grajek M., et al. Assessment of the risk of depression in residents staying at long-term care institutions in Poland during the COVID-19 pandemic depending on the quality of cognitive functioning. Front Psychol. 2021;12:766675. doi: 10.3389/fpsyg.2021.766675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 193.Couderc A.L., Correard F., Nouguerède E., et al. Centenarians in nursing homes during the COVID-19 pandemic. Aging (Albany NY) 2021;13:6247–6257. doi: 10.18632/aging.202743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 194.Levere M., Rowan P., Wysocki A. The adverse effects of the COVID-19 pandemic on nursing home resident well-being. J Am Med Dir Assoc. 2021;22:948–954.e942. doi: 10.1016/j.jamda.2021.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 195.Pereiro A.X., Dosil-Díaz C., Mouriz-Corbelle R., et al. Impact of the COVID-19 lockdown on a long-term care facility: the role of social contact. Brain Sci. 2021;11:986. doi: 10.3390/brainsci11080986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 196.Ho K.H.M., Mak A.K.P., Chung R.W.M., et al. Implications of COVID-19 on the loneliness of older adults in residential care homes. Qual Health Res. 2022;32:279–290. doi: 10.1177/10497323211050910. [DOI] [PubMed] [Google Scholar]
  • 197.Hua C.L., Thomas K.S. Coronavirus disease 19 (COVID-19) restrictions and loneliness among residents in long-term care communities: data from the National Health and Aging Trends Study. J Am Med Dir Assoc. 2021;22:1860–1861. doi: 10.1016/j.jamda.2021.06.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 198.Huber A., Seifert A. Retrospective feelings of loneliness during the COVID-19 pandemic among residents of long-term care facilities. Aging Health Res. 2022;2:100053. doi: 10.1016/j.ahr.2022.100053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 199.Kaelen S., van den Boogaard W., Pellecchia U., et al. How to bring residents' psychosocial well-being to the heart of the fight against Covid-19 in Belgian nursing homes—a qualitative study. PLoS One. 2021;16:e0249098. doi: 10.1371/journal.pone.0249098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 200.Bergman C., Stall N.M., Haimowitz D., et al. Recommendations for welcoming back nursing home visitors during the COVID-19 pandemic: results of a Delphi panel. J Am Med Dir Assoc. 2020;21:1759–1766. doi: 10.1016/j.jamda.2020.09.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 201.Hovey S., Shropshire M.D. Informal caregivers' perspectives on the mandated no visitation policy during COVID-19 pandemic in long-term care: a qualitative study. J Gerontol Nurs. 2021;47:19–26. doi: 10.3928/00989134-20211109-05. [DOI] [PubMed] [Google Scholar]
  • 202.Monin J.K., Ali T., Syed S., et al. Family communication in long-term care during a pandemic: lessons for enhancing emotional experiences. Am J Geriatr Psychiatry. 2020;28:1299–1307. doi: 10.1016/j.jagp.2020.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 203.Veiga-Seijo R., Miranda-Duro M.D.C., Veiga-Seijo S. Strategies and actions to enable meaningful family connections in nursing homes during the COVID-19: a scoping review. Clin Gerontol. 2022;45:20–30. doi: 10.1080/07317115.2021.1937424. [DOI] [PubMed] [Google Scholar]
  • 204.Wammes J.D., Kolk M.D., van den Besselaar Md JH., et al. Evaluating perspectives of relatives of nursing home residents on the nursing home visiting restrictions during the COVID-19 crisis: a Dutch cross-sectional survey study. J Am Med Dir Assoc. 2020;21:1746–1750.e1743. doi: 10.1016/j.jamda.2020.09.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 205.Yeh T.C., Huang H.C., Yeh T.Y., et al. Family members' concerns about relatives in long-term care facilities: acceptance of visiting restriction policy amid the COVID-19 pandemic. Geriatr Gerontol Int. 2020;20:938–942. doi: 10.1111/ggi.14022. [DOI] [PubMed] [Google Scholar]
  • 206.Feder S., Smith D., Griffin H., et al. "Why couldn't I go in to see him?" Bereaved families' perceptions of end-of-life communication during COVID-19. J Am Geriatr Soc. 2021;69:587–592. doi: 10.1111/jgs.16993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 207.Blanco-Donoso L.M., Moreno-Jiménez J., Amutio A., et al. Stressors, job resources, fear of contagion, and secondary traumatic stress among nursing home workers in face of the COVID-19: the case of Spain. J Appl Gerontol. 2021;40:244–256. doi: 10.1177/0733464820964153. [DOI] [PubMed] [Google Scholar]
  • 208.Lethin C., Kenkmann A., Chiatti C., et al. Organizational support experiences of care home and home care staff in Sweden, Italy, Germany and the United Kingdom during the COVID-19 pandemic. Healthcare (Basel) 2021;9:767. doi: 10.3390/healthcare9060767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 209.Blanco-Donoso L.M., Moreno-Jiménez J., Gallego-Alberto L., et al. Satisfied as professionals, but also exhausted and worried!!: The role of job demands, resources and emotional experiences of Spanish nursing home workers during the COVID-19 pandemic. Health Soc Care Community. 2022;30:e148–e160. doi: 10.1111/hsc.13422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 210.Cimarolli V.R., Bryant N.S., Falzarano F., et al. Job resignation in nursing homes during the COVID-19 pandemic: the role of quality of employer communication. J Appl Gerontol. 2022;41:12–21. doi: 10.1177/07334648211040509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 211.Snyder R.L., Anderson L.E., White K.A., et al. A qualitative assessment of factors affecting nursing home caregiving staff experiences during the COVID-19 pandemic. PLoS One. 2021;16:e0260055. doi: 10.1371/journal.pone.0260055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 212.Werner R.M., Hoffman A.K., Coe N.B. Long-term care policy after Covid-19 - solving the nursing home crisis. N Engl J Med. 2020;383:903–905. doi: 10.1056/NEJMp2014811. [DOI] [PubMed] [Google Scholar]
  • 213.O'Neill D. Protecting our longevity dividend during Covid-19. Ir Med J. 2020;113:50. [PubMed] [Google Scholar]
  • 214.O'Neill D., Briggs R., Holmerová I., et al. COVID-19 highlights the need for universal adoption of standards of medical care for physicians in nursing homes in Europe. Eur Geriatr Med. 2020;11:645–650. doi: 10.1007/s41999-020-00347-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 215.Werner R.M., Konetzka R.T. Reimagining financing and payment of long-term care. J Am Med Dir Assoc. 2021;23:220–224. doi: 10.1016/j.jamda.2021.11.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 216.Briggs R., Holmerova I., Martin F.C., et al. Towards standards of medical care for physicians in nursing homes. Eur Geriatr Med. 2015;6:401–403. doi: 10.1007/s41999-020-00347-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 217.Committee on the Quality of Care in Nursing Homes, Board on Health Care Services, Health and Medicine Division . National Academic Press; 2022. The National Imperative To IMprove Nursing Home Quality. A Consensus Study Report of the National Academies of Sciences Engineering Medicine. [Google Scholar]
  • 218.Zimmerman S., Cesari M., Gaugler J.E., et al. The inevitability of reimagining long-term care. J Am Med Dir Assoc. 2022;23:187–189. doi: 10.1016/j.jamda.2021.12.032. [DOI] [PubMed] [Google Scholar]
  • 219.The Lancet Reimagining long-term care. Lancet. 2020;396:1307. doi: 10.1016/S0140-6736(20)32202-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the American Medical Directors Association are provided here courtesy of Elsevier

RESOURCES